Stock | Market Cap |
Dividend Yield | P/E Ratio | Dividend Frequency |
Years Paying |
DGR |
000990.SZ CHENGZHI CO. LTD.
|
1.4 billion |
0.00% |
38.41
|
- |
2 |
-
|
002007.SZ HUALAN BIOLOGICA.E
|
4.2 billion |
1.74% |
23.32
|
- |
16 |
11%
|
002030.SZ DAAN GENE CO LTD
|
1.2 billion |
0.00% |
-12.04
|
- |
20 |
30%
|
002252.SZ S/H RAAS BLOOD PRO
|
6.8 billion |
0.00% |
26.89
|
- |
5 |
30%
|
002286.SZ BAOLINGBAO BIOLOGY
|
405.6 million |
1.29% |
26.57
|
1 |
13 |
30%
|
002566.SZ JILIN JIAN YISHENG
|
344.8 million |
0.02% |
34.41
|
1 |
5 |
-
|
002653.SZ HAISCO PHARMACEUTI
|
5.9 billion |
0.01% |
89.53
|
1 |
1 |
-
|
002880.SZ SHENZHEN WEIGUANG
|
909.9 million |
0.69% |
26.50
|
1 |
7 |
-
|
003020.SZ HEFEI LIFEON PHARM
|
505.6 million |
0.02% |
21.50
|
- |
4 |
30%
|
048530.KQ iNtRON Bio
|
124.7 million |
- |
-
|
- |
1 |
-
|
064550.KQ BIONEER
|
342.9 million |
0.00% |
-
|
- |
- |
-
|
068270.KS Celltrion
|
24.5 billion |
0.30% |
-
|
1 |
3 |
-
|
095700.KQ Genexine
|
194.5 million |
0.00% |
-
|
- |
- |
-
|
096530.KQ SEEGENE
|
743.2 million |
3.64% |
-
|
3 |
6 |
-15%
|
1177.HK SINO BIOPHARM
|
8.1 billion |
1.57% |
26.54
|
4 |
21 |
20%
|
1530.HK 3SBIO
|
1.9 billion |
0.04% |
8.67
|
- |
3 |
-
|
1733.TW APEX BIOTECHNOLOGY CORP
|
87.5 million |
0.03% |
27.26
|
1 |
21 |
-
|
1734.TW SINPHAR PHARMACEUTICAL CO LTD
|
173.4 million |
0.03% |
16.85
|
- |
22 |
-
|
1760.TW PANION & BF BIOTECH INC
|
238.3 million |
1.62% |
63.83
|
- |
10 |
-
|
1762.TW CHUNGHWA CHEMICAL SYNTHESIS BIO
|
91.5 million |
0.00% |
30.32
|
- |
15 |
-8%
|
206A.T PRISM BIOLAB CO LTD
|
79.5 million |
- |
-22.33
|
- |
- |
-
|
216080.KQ JETEMA
|
217.7 million |
0.00% |
-
|
- |
- |
-
|
2183.T LINICAL CO LTD
|
51.0 million |
0.00% |
24.08
|
1 |
16 |
3%
|
226950.KQ OliX
|
234.0 million |
0.00% |
-
|
- |
- |
-
|
235980.KQ MedPacto
|
125.2 million |
0.00% |
-
|
- |
- |
-
|
2385.T SOIKEN HOLDINGS INC
|
22.9 million |
0.03% |
-5.21
|
- |
8 |
5%
|
299660.KQ Cellid
|
81.9 million |
0.00% |
-
|
- |
- |
-
|
300009.SZ ANHUI ANKE BIOTECH
|
2.0 billion |
0.03% |
19.23
|
- |
15 |
18%
|
300122.SZ CHONGQING ZHIFEI B
|
9.6 billion |
0.03% |
19.15
|
- |
14 |
26%
|
300181.SZ ZHEJIANG JOLLY PHA
|
1.6 billion |
0.03% |
23.18
|
1 |
13 |
30%
|
300294.SZ CHINA RESOURCES BO
|
2.2 billion |
1.38% |
85.30
|
- |
13 |
30%
|
300381.SZ GUANGDONG VTR BIO-
|
532.9 million |
0.01% |
202
|
- |
11 |
-
|
300583.SZ SHANDONG SITO BIO
|
620.1 million |
0.04% |
-139.71
|
- |
3 |
-
|
300653.SZ YANTAI ZHENGHAI BI
|
561.3 million |
0.04% |
24.45
|
- |
7 |
30%
|
300841.SZ Chengdu Kanghua Biological Products Co., Ltd.
|
1.1 billion |
- |
13.94
|
1 |
4 |
30%
|
300871.SZ HVSEN BIOTECHNOLOG
|
296.6 million |
0.02% |
-46.64
|
- |
4 |
-
|
300878.SZ ZHEJIANG WECOME PH
|
369.7 million |
0.01% |
-82.22
|
- |
1 |
-
|
300966.SZ HUBEI GOTO BIOPHAR
|
303.2 million |
0.00% |
-159.25
|
- |
1 |
-
|
301207.SZ HUALAN BIOLOGICAL
|
1.6 billion |
0.03% |
23.83
|
- |
3 |
-
|
3164.TW GENMONT BIOTECH INC
|
54.2 million |
0.00% |
33.28
|
- |
5 |
-
|
3759.HK PHARMARON
|
6.3 billion |
0.02% |
12.33
|
- |
1 |
-
|
4130.TWO GENOVATE BIOTECHNOLOGY CO. LTD.
|
75.8 million |
0.01% |
156.79
|
- |
12 |
-6%
|
4133.TW ABNOVA (TAIWAN) CORPORATION
|
54.0 million |
0.02% |
29.79
|
- |
14 |
-
|
4162.TWO PHARMAENGINE INC
|
418.8 million |
1.42% |
36.73
|
- |
10 |
30%
|
4167.TWO SAVIOR LIFETEC CORPORATION
|
201.9 million |
0.00% |
36.79
|
- |
2 |
-
|
4169.TWO TCM
|
108.1 million |
0.01% |
174.41
|
1 |
1 |
-
|
4732.TWO NBM
|
38.1 million |
0.00% |
92.59
|
1 |
3 |
-
|
4880.T CELLSOURCE CO LTD
|
155.0 million |
0.00% |
28.27
|
- |
2 |
-
|
4911.TWO G&E HERBAL BIOTECHNOLOGY CO. LT
|
108.2 million |
0.01% |
39.08
|
- |
- |
-
|
4974.T TAKARA BIO INC
|
859.0 million |
1.52% |
142.82
|
1 |
13 |
30%
|
600161.SS BEIJING TIANTAN BIOLOGICAL PROD
|
5.8 billion |
0.00% |
33.41
|
- |
7 |
-
|
600201.SS JINYU BIO-TECHNOLOGY CO LTD
|
1.1 billion |
0.01% |
47
|
- |
13 |
-3%
|
600866.SS STAR LAKE BIOSCIENCE CO INC Z
|
1.6 billion |
0.06% |
13.21
|
- |
- |
-
|
603233.SS DASHENLIN PHARMACEUTICAL GROUP
|
2.4 billion |
4.26% |
20.84
|
- |
7 |
14%
|
603392.SS BEIJING WANTAI BIOLOGICAL PHARM
|
13.1 billion |
0.00% |
-327.39
|
- |
3 |
-
|
603439.SS GUIZHOU SANLI PHARMACEUTICAL CO
|
799.0 million |
0.01% |
18.06
|
- |
1 |
-
|
603566.SS PULIKE BIOLOGICAL
|
638.4 million |
0.05% |
46.55
|
- |
8 |
-
|
603718.SS SHANGHAI HILE BIO-
|
715.3 million |
0.00% |
807
|
- |
2 |
-
|
603739.SS QINGDAO VLAND BIOTECH CO LTD
|
489.0 million |
0.01% |
54
|
- |
6 |
-30%
|
603896.SS ZHEJIANG SHOUXIANGU PHARMACEUTI
|
631.9 million |
0.01% |
19.46
|
- |
7 |
-
|
605116.SS AURISCO PHARMACEUTICAL CO LTD
|
1.2 billion |
0.01% |
26.20
|
- |
4 |
23%
|
6821.HK ASYMCHEM
|
4.0 billion |
0.03% |
22.70
|
1 |
3 |
-
|
6826.HK HAOHAI BIOTEC
|
1.9 billion |
0.02% |
14.04
|
- |
9 |
5%
|
6848.TWO RBC
|
7.7 million |
0.02% |
14.47
|
2 |
2 |
-
|
688075.SS ASSURE TECH (HANGZHOU) CO LTD
|
705.4 million |
0.01% |
56.80
|
- |
3 |
-
|
688076.SS SINOPEP-ALLSINO BIO PHARMACEUTI
|
1.6 billion |
0.01% |
27.04
|
- |
3 |
-
|
688098.SS SHANGHAI SHEN LIAN BIOMEDICAL C
|
322.2 million |
0.01% |
-142.50
|
- |
5 |
-26%
|
688105.SS NANJING VAZYME BIOTECH CO LTD
|
1.4 billion |
0.01% |
416.33
|
- |
3 |
-
|
688278.SS XIAMEN AMOYTOP BIOTECH CO LTD
|
4.1 billion |
0.01% |
40.27
|
1 |
4 |
-
|
688366.SS SHANGHAI HAOHAI BIOLOGICAL TECH
|
1.9 billion |
0.01% |
35.21
|
- |
4 |
-
|
688526.SS WUHAN KEQIAN BIOLOGY CO LTD
|
983.5 million |
0.02% |
24.05
|
1 |
4 |
-
|
688578.SS SHANGHAI ALLIST PHARMACEUTICALS
|
3.7 billion |
0.01% |
20.89
|
- |
1 |
-
|
688639.SS ANHUI HUAHENG BIOTECHNOLOGY CO
|
1.2 billion |
0.01% |
28.01
|
- |
4 |
30%
|
688687.SS BEIJING KAWIN TECHNOLOGY SHARE-
|
614.4 million |
0.01% |
32.91
|
1 |
4 |
-
|
688767.SS HANGZHOU BIOTEST BIOTECH CO LTD
|
485.4 million |
0.03% |
34.08
|
- |
3 |
-
|
7096.T STEMCELL INSTITUTE
|
97.6 million |
0.00% |
34.67
|
- |
1 |
-
|
AADI Aadi Bioscience, Inc.
|
60.9 million |
0.00% |
-
|
- |
- |
-
|
ABCL AbCellera Biologics Inc.
|
841.8 million |
0.00% |
-
|
- |
- |
-
|
ABCM Abcam plc
|
5.5 billion |
0.75% |
2397
|
- |
- |
-
|
ABEO Abeona Therapeutics Inc.
|
264.7 million |
0.00% |
-
|
- |
- |
-
|
ABIO ARCA biopharma, Inc.
|
40.8 million |
0.00% |
-4.32
|
- |
1 |
-
|
ABSI Absci Corporation
|
326.2 million |
0.00% |
-
|
- |
- |
-
|
ABUS Arbutus Biopharma Corporation
|
697.3 million |
0.00% |
-
|
- |
- |
-
|
ABVC ABVC Biopharma, Inc.
|
6.2 million |
0.00% |
-0.36
|
- |
- |
-
|
ACAD ACADIA Pharmaceuticals Inc.
|
2.9 billion |
0.00% |
22.15
|
- |
- |
-
|
ACER Acer Therapeutics Inc.
|
16.1 million |
3.50% |
-1.35
|
- |
- |
-
|
ACET Adicet Bio, Inc.
|
87.3 million |
0.00% |
-
|
2 |
- |
-
|
ACHL Achilles Therapeutics plc
|
44.8 million |
0.00% |
-0.50
|
- |
- |
-
|
ACHV Achieve Life Sciences, Inc.
|
155.3 million |
0.00% |
-2.15
|
- |
- |
-
|
ACIU AC Immune SA
|
316.6 million |
0.00% |
-
|
- |
- |
-
|
ACST Acasti Pharma, Inc.
|
33.2 million |
0.00% |
-0.41
|
- |
- |
-
|
ACXP Acurx Pharmaceuticals, Inc.
|
12.7 million |
0.00% |
-3.04
|
- |
- |
-
|
ADAG Adagene Inc.
|
95.2 million |
0.00% |
-4.13
|
- |
- |
-
|
ADAP Adaptimmune Therapeutics plc
|
185.1 million |
0.00% |
-
|
- |
- |
-
|
ADCT ADC Therapeutics SA
|
283.3 million |
0.00% |
-
|
- |
- |
-
|
ADGI Adagio Therapeutics, Inc.
|
505.0 million |
- |
-
|
- |
- |
-
|
ADIL Adial Pharmaceuticals, Inc
|
7.7 million |
0.00% |
-0.14
|
- |
- |
-
|
ADMA ADMA Biologics Inc
|
4.7 billion |
0.00% |
72.87
|
- |
- |
-
|
ADPT Adaptive Biotechnologies Corpor
|
925.3 million |
0.00% |
-
|
- |
- |
-
|
ADTX Aditxt, Inc.
|
5.0 million |
0.00% |
0.00
|
- |
- |
-
|
ADVM Adverum Biotechnologies, Inc.
|
164.1 million |
0.00% |
-
|
- |
- |
-
|
ADXN Addex Therapeutics Ltd
|
8.6 million |
0.00% |
-
|
- |
- |
-
|
ADXS Ayala Pharmaceuticals, Inc.
|
1.2 million |
0.00% |
-0.34
|
- |
- |
-
|
AEON
|
- |
- |
-
|
- |
- |
-
|
AEZS Aeterna Zentaris Inc.
|
18.1 million |
0.00% |
-0.37
|
- |
- |
-
|
AFMD Affimed N.V.
|
38.7 million |
0.00% |
-
|
- |
- |
-
|
AGE AgeX Therapeutics, Inc.
|
33.2 million |
0.00% |
-1.02
|
- |
- |
-
|
AGEN Agenus Inc.
|
84.5 million |
0.00% |
-
|
- |
- |
-
|
AGIO Agios Pharmaceuticals, Inc.
|
3.4 billion |
0.00% |
5.07
|
- |
- |
-
|
AGLE Spyre Therapeutics, Inc.
|
48.6 million |
- |
-4.70
|
- |
- |
-
|
AGTC Applied Genetic Technologies Corporation
|
26.6 million |
- |
-2.28
|
- |
- |
-
|
AIKI AIkido Pharma Inc.
|
19.4 million |
- |
-0.24
|
- |
- |
-
|
AIM AIM ImmunoTech Inc.
|
13.5 million |
0.00% |
-
|
- |
- |
-
|
AKRO Akero Therapeutics, Inc.
|
2.2 billion |
0.00% |
-7.66
|
- |
- |
-
|
AKTX Akari Therapeutics Plc
|
29.8 million |
0.00% |
-1
|
- |
- |
-
|
AKUS Akouos, Inc.
|
491.0 million |
- |
-
|
- |
- |
-
|
ALBO Albireo Pharma, Inc.
|
920.7 million |
- |
-11.67
|
- |
- |
-
|
ALDX Aldeyra Therapeutics, Inc.
|
299.5 million |
0.00% |
-
|
- |
- |
-
|
ALEC Alector, Inc.
|
215.5 million |
0.00% |
-
|
- |
- |
-
|
ALGS Aligos Therapeutics, Inc.
|
70.7 million |
0.00% |
-
|
- |
- |
-
|
ALK-B.CO ALK-Abelló B A/S
|
5.0 billion |
0.00% |
46.50
|
- |
- |
-
|
ALLK Allakos Inc.
|
98.3 million |
0.00% |
-0.80
|
- |
- |
-
|
ALLO Allogene Therapeutics, Inc.
|
448.7 million |
0.00% |
-
|
- |
- |
-
|
ALLR Allarity Therapeutics, Inc.
|
1.9 million |
0.00% |
0.00
|
- |
- |
-
|
ALNA Allena Pharmaceuticals, Inc.
|
9.2 million |
- |
-1.19
|
- |
- |
-
|
ALNY Alnylam Pharmaceuticals, Inc.
|
33.3 billion |
0.00% |
-
|
- |
- |
-
|
ALPN Alpine Immune Sciences, Inc.
|
4.5 billion |
0.00% |
-22.30
|
- |
- |
-
|
ALRN Aileron Therapeutics, Inc.
|
47.7 million |
0.00% |
-1.64
|
- |
- |
-
|
ALT Altimmune, Inc.
|
650.1 million |
0.00% |
-
|
- |
- |
-
|
ALVR AlloVir, Inc.
|
61.2 million |
0.00% |
-0.43
|
- |
- |
-
|
ALXN Alexion Pharmaceuticals, Inc.
|
40.3 billion |
- |
59.23
|
- |
- |
-
|
ALXO ALX Oncology Holdings Inc.
|
90.7 million |
0.00% |
-4.38
|
- |
- |
-
|
ALZN Alzamend Neuro, Inc.
|
6.7 million |
0.00% |
-0.38
|
- |
- |
-
|
AMAM Ambrx Biopharma Inc.
|
1.8 billion |
0.00% |
66.14
|
- |
- |
-
|
AMLX Amylyx Pharmaceuticals, Inc.
|
352.3 million |
0.00% |
-
|
- |
- |
-
|
AMPE Ampio Pharmaceuticals, Inc.
|
1135 |
0.00% |
-0.15
|
- |
- |
-
|
AMTI Applied Molecular Transport Inc.
|
11.0 million |
- |
-0.14
|
- |
- |
-
|
ANAB AnaptysBio, Inc.
|
578.0 million |
- |
68.66
|
- |
- |
-
|
ANEB Anebulo Pharmaceuticals, Inc.
|
40.2 million |
0.00% |
-5.39
|
- |
- |
-
|
ANGN Angion Biomedica Corp.
|
20.4 million |
- |
-
|
- |
- |
-
|
ANIX Anixa Biosciences, Inc.
|
104.6 million |
0.00% |
-14.37
|
- |
- |
-
|
ANNX Annexon, Inc.
|
668.8 million |
0.00% |
-2.69
|
- |
- |
-
|
ANPC Fresh2 Group Limited
|
27.0 million |
- |
-
|
- |
- |
-
|
ANTH Anthera Pharmaceuticals, Inc.
|
6178 |
- |
0.00
|
- |
- |
-
|
ANTX AN2 Therapeutics, Inc.
|
30.1 million |
0.00% |
-7.50
|
3 |
- |
-
|
ANVS Annovis Bio, Inc.
|
98.3 million |
0.00% |
-2.06
|
- |
- |
-
|
APLS Apellis Pharmaceuticals, Inc.
|
3.7 billion |
0.00% |
-
|
- |
- |
-
|
APLT Applied Therapeutics, Inc.
|
144.3 million |
0.00% |
-
|
- |
- |
-
|
APM Aptorum Group Limited
|
7.0 million |
- |
2.70
|
- |
- |
-
|
APOP Cellect Biotechnology Ltd.
|
51.5 million |
- |
-0.82
|
- |
- |
-
|
APRE Aprea Therapeutics, Inc.
|
19.3 million |
0.00% |
-
|
- |
- |
-
|
APTO Aptose Biosciences, Inc.
|
7.5 million |
0.00% |
-0.27
|
- |
- |
-
|
APTX Aptinyx Inc.
|
4.4 million |
- |
-2.48
|
- |
- |
-
|
APVO Aptevo Therapeutics Inc.
|
3.7 million |
0.00% |
-0.06
|
- |
- |
-
|
ARAV Aravive, Inc.
|
2.9 million |
- |
-0.05
|
- |
- |
-
|
ARBS.MI ARTERRA BIOSCIENCE
|
13.6 million |
- |
9.19
|
- |
3 |
-
|
ARCT Arcturus Therapeutics Holdings
|
517.1 million |
0.00% |
-
|
1 |
- |
-
|
ARDS Aridis Pharmaceuticals Inc.
|
4457 |
0.00% |
-
|
- |
- |
-
|
ARDX Ardelyx, Inc.
|
1.4 billion |
0.00% |
-
|
- |
- |
-
|
ARGX argenx SE
|
36.0 billion |
0.00% |
-
|
- |
- |
-
|
ARMP Armata Pharmaceuticals, Inc.
|
81.1 million |
0.00% |
-
|
- |
- |
-
|
ARNA Arena Pharmaceuticals, Inc.
|
6.2 billion |
- |
-6.17
|
- |
- |
-
|
ARQT Arcutis Biotherapeutics, Inc.
|
1.5 billion |
0.00% |
-
|
- |
- |
-
|
ARTL Artelo Biosciences, Inc.
|
3.5 million |
0.00% |
-0.41
|
- |
- |
-
|
ARVN Arvinas, Inc.
|
1.8 billion |
0.00% |
-
|
- |
- |
-
|
ARWR Arrowhead Pharmaceuticals, Inc.
|
2.9 billion |
0.00% |
-
|
- |
- |
-
|
ASLN ASLAN Pharmaceuticals Limited
|
6.7 million |
0.00% |
-0.19
|
- |
- |
-
|
ASMB Assembly Biosciences, Inc.
|
102.0 million |
0.00% |
-
|
- |
- |
-
|
ASND Ascendis Pharma A/S
|
7.4 billion |
0.00% |
-
|
- |
- |
-
|
ATAI ATAI Life Sciences N.V.
|
226.5 million |
0.00% |
-4.16
|
1 |
- |
-
|
ATHA Athira Pharma, Inc.
|
28.2 million |
0.00% |
-0.98
|
- |
- |
-
|
ATHE Alterity Therapeutics Limited
|
17.0 million |
0.00% |
-1.05
|
- |
- |
-
|
ATHX Athersys, Inc.
|
459479 |
1.02% |
0.72
|
- |
- |
-
|
ATNF 180 Life Sciences Corp.
|
3.0 million |
0.00% |
-0.01
|
- |
- |
-
|
ATNFW 180 Life Sciences Corp.
|
250.8 million |
0.00% |
-
|
- |
- |
-
|
ATNM Actinium Pharmaceuticals, Inc.
|
59.9 million |
0.00% |
-2.83
|
- |
- |
-
|
ATOS Atossa Therapeutics, Inc.
|
153.5 million |
0.00% |
-3.95
|
- |
- |
-
|
ATRA Atara Biotherapeutics, Inc.
|
71.6 million |
0.00% |
-
|
- |
- |
-
|
ATXI Avenue Therapeutics, Inc.
|
3.6 million |
0.00% |
0.08
|
- |
- |
-
|
ATXS Astria Therapeutics, Inc.
|
572.2 million |
0.00% |
-7.08
|
- |
- |
-
|
AUPH Aurinia Pharmaceuticals Inc
|
1.3 billion |
0.00% |
-
|
- |
- |
-
|
AURA Aura Biosciences, Inc.
|
423.6 million |
0.00% |
-4.10
|
- |
- |
-
|
AUTL Autolus Therapeutics plc
|
782.4 million |
0.00% |
-
|
- |
- |
-
|
AVEO AVEO Pharmaceuticals, Inc.
|
521.4 million |
- |
-3.94
|
- |
- |
-
|
AVIR Atea Pharmaceuticals, Inc.
|
281.3 million |
0.00% |
-2.56
|
- |
- |
-
|
AVRO AVROBIO, Inc.
|
68.2 million |
0.00% |
2.20
|
- |
- |
-
|
AVTX Avalo Therapeutics, Inc.
|
106.2 million |
0.00% |
0.11
|
- |
- |
-
|
AVXL Anavex Life Sciences Corp.
|
680.9 million |
0.00% |
-9.09
|
- |
- |
-
|
AXLA Axcella Health Inc.
|
1.2 million |
- |
-0.02
|
- |
- |
-
|
AXSM Axsome Therapeutics, Inc.
|
4.8 billion |
0.00% |
-
|
- |
- |
-
|
AYLA Ayala Pharmaceuticals, Inc.
|
7.5 million |
- |
-
|
- |
- |
-
|
AZRX AzurRx BioPharma, Inc.
|
271.1 million |
- |
-1.26
|
- |
- |
-
|
BAVA.CO Bavarian Nordic A/S
|
2.2 billion |
0.00% |
13.49
|
- |
- |
-
|
BBI Brickell Biotech, Inc.
|
6.8 million |
- |
-0.60
|
- |
- |
-
|
BBIO BridgeBio Pharma, Inc.
|
5.4 billion |
0.00% |
-
|
- |
- |
-
|
BBZA.DE BB Biotech AG N
|
2.4 billion |
4.89% |
16.48
|
1 |
12 |
-6%
|
BCAB BioAtla, Inc.
|
79.3 million |
0.00% |
-0.93
|
- |
- |
-
|
BCAX Bicara Therapeutics Inc. Common Stock
|
1.1 billion |
0.00% |
-17.91
|
- |
- |
-
|
BCDA BioCardia, Inc.
|
9.4 million |
0.00% |
-
|
- |
- |
-
|
BCDAW BioCardia, Inc.
|
4.4 million |
0.00% |
-0.01
|
- |
- |
-
|
BCEL Atreca, Inc.
|
3.6 million |
0.00% |
-0.11
|
- |
- |
-
|
BCLI Brainstorm Cell Therapeutics In
|
9.3 million |
0.00% |
-0.92
|
- |
- |
-
|
BCRX BioCryst Pharmaceuticals, Inc.
|
1.5 billion |
0.00% |
-
|
- |
- |
-
|
BCTX BriaCell Therapeutics Corp.
|
45.5 million |
0.00% |
-2.27
|
- |
- |
-
|
BCTXW BriaCell Therapeutics Corp.
|
48.1 million |
0.00% |
-
|
- |
- |
-
|
BCYC Bicycle Therapeutics plc
|
1.3 billion |
0.00% |
-
|
- |
- |
-
|
BDTX Black Diamond Therapeutics, Inc
|
161.3 million |
0.00% |
-2.51
|
- |
- |
-
|
BEAM Beam Therapeutics Inc.
|
2.3 billion |
0.00% |
-
|
4 |
- |
-
|
BFRA Biofrontera AG
|
80.2 million |
- |
-8.15
|
- |
- |
-
|
BGBIO.OL BERGENBIO
|
36.0 million |
0.00% |
-5.86
|
- |
- |
-
|
BGNE BeiGene, Ltd.
|
23.5 billion |
0.00% |
-
|
- |
- |
-
|
BHVN Biohaven Ltd.
|
4.9 billion |
0.00% |
-6.15
|
- |
- |
-
|
BIO3.DE BIOTEST AG VZ O.N.
|
1.4 billion |
0.00% |
15.72
|
1 |
- |
-
|
BIOCON.BO BIOCON LTD.
|
5.3 billion |
0.00% |
31.15
|
- |
3 |
-
|
BIOCON.NS BIOCON LTD
|
5.3 billion |
0.16% |
31.13
|
- |
3 |
-
|
BIO.DE BIOTEST AG ST O.N.
|
1.4 billion |
0.00% |
23.93
|
1 |
- |
-
|
BION.SW BB BIOTECH N
|
2.5 billion |
5.15% |
17.25
|
1 |
12 |
-6%
|
BIVI BioVie Inc.
|
50.1 million |
0.00% |
-0.79
|
- |
- |
-
|
BLCM Bellicum Pharmaceuticals, Inc.
|
778326 |
0.00% |
-0.13
|
- |
- |
-
|
BLI Berkeley Lights, Inc.
|
86.6 million |
- |
-
|
- |
- |
-
|
BLPH Bellerophon Therapeutics, Inc.
|
452606 |
0.00% |
-0.07
|
- |
- |
-
|
BLRX BioLineRx Ltd.
|
21.0 million |
0.00% |
-
|
- |
- |
-
|
BLU BELLUS Health Inc.
|
1.8 billion |
- |
-4.06
|
- |
- |
-
|
BLUE bluebird bio, Inc.
|
64.7 million |
0.00% |
-
|
- |
- |
-
|
BLUEJET.BO Blue Jet Healthcare Limited
|
1.1 billion |
0.00% |
54.99
|
- |
- |
-
|
BLUEJET.NS BLUE JET HEALTHCARE LTD
|
1.1 billion |
0.00% |
54.84
|
- |
1 |
-
|
BMEA Biomea Fusion, Inc.
|
221.1 million |
0.00% |
-6.17
|
- |
- |
-
|
BMRN BioMarin Pharmaceutical Inc.
|
12.1 billion |
0.00% |
38.20
|
- |
- |
-
|
BNOX Bionomics Limited - American De
|
5.7 million |
0.00% |
-0.38
|
- |
- |
-
|
BNTC Benitec Biopharma Inc.
|
206.1 million |
0.00% |
-0.01
|
- |
- |
-
|
BNTX BioNTech SE
|
28.1 billion |
0.00% |
-
|
- |
- |
-
|
BOLT Bolt Biotherapeutics, Inc.
|
21.5 million |
0.00% |
-
|
4 |
- |
-
|
BOT.AX BOTANIX FPO [BOT]
|
373.5 million |
0.00% |
-19
|
- |
- |
-
|
BPMC Blueprint Medicines Corporation
|
6.1 billion |
0.00% |
-
|
- |
- |
-
|
BPTH Bio-Path Holdings, Inc.
|
3.4 million |
0.00% |
-0.23
|
- |
- |
-
|
BRAX.CN BraxiaScience
|
1.0 million |
0.00% |
-0.10
|
- |
- |
-
|
BRNS Barinthus Biotherapeutics plc
|
38.9 million |
- |
-0.66
|
- |
- |
-
|
BRTX BioRestorative Therapies, Inc.
|
10.3 million |
0.00% |
-
|
- |
- |
-
|
BSTG Harvard Apparatus Regenerative Technology Inc.
|
81.3 million |
- |
-2.69
|
- |
- |
-
|
BTAI BioXcel Therapeutics, Inc.
|
25.8 million |
0.00% |
-
|
- |
- |
-
|
BTTX Better Therapeutics, Inc.
|
5452 |
0.00% |
-
|
- |
- |
-
|
BTX Eterna Therapeutics Inc.
|
12.0 million |
- |
17.81
|
- |
- |
-
|
BVXP.L BIOVENTIX PLC ORD 5P
|
2.5 million |
0.04% |
24.58
|
2 |
11 |
4%
|
BVXV BiondVax Pharmaceuticals Ltd.
|
6.3 million |
- |
-0.95
|
- |
- |
-
|
BYSI BeyondSpring, Inc.
|
78.2 million |
0.00% |
-
|
- |
- |
-
|
CABA Cabaletta Bio, Inc.
|
184.6 million |
0.00% |
-14.71
|
- |
- |
-
|
CADL Candel Therapeutics, Inc.
|
146.5 million |
0.00% |
-1.54
|
- |
- |
-
|
CALA Calithera Biosciences, Inc.
|
487 |
0.00% |
-3.31
|
- |
- |
-
|
CALT Calliditas Therapeutics AB
|
1.1 billion |
0.00% |
-
|
- |
- |
-
|
CAMP CAMP4 THERAPEUTICS CORPORATION
|
182.1 million |
0.00% |
-
|
- |
- |
-
|
CANF Can-Fite Biopharma Ltd Sponsore
|
9.8 million |
0.00% |
-
|
- |
- |
-
|
CAPR Capricor Therapeutics, Inc.
|
839.4 million |
0.00% |
-
|
- |
- |
-
|
CARA Cara Therapeutics, Inc.
|
14.6 million |
0.00% |
-
|
- |
- |
-
|
CARM Carisma Therapeutics, Inc.
|
35.2 million |
0.00% |
-0.56
|
- |
1 |
-
|
CASI CASI Pharmaceuticals, Inc.
|
52.9 million |
0.00% |
-
|
- |
- |
-
|
CATB Catabasis Pharmaceuticals, Inc.
|
657.1 million |
- |
-0.66
|
- |
- |
-
|
CBAY CymaBay Therapeutics, Inc.
|
3.7 billion |
0.00% |
-34.58
|
- |
- |
-
|
CBIO Catalyst Biosciences, Inc.
|
19.4 million |
792.92% |
1.67
|
- |
- |
-
|
CBLI Cleveland BioLabs, Inc.
|
49.0 million |
0.00% |
-16.82
|
- |
- |
-
|
CCCC C4 Therapeutics, Inc.
|
310.6 million |
0.00% |
-
|
- |
- |
-
|
CCXI ChemoCentryx, Inc.
|
3.7 billion |
4.97% |
-91.33
|
- |
- |
-
|
CDAK Codiak BioSciences, Inc.
|
2.8 million |
- |
-
|
- |
- |
-
|
CDMO Avid Bioservices, Inc.
|
784.7 million |
0.00% |
-
|
- |
- |
-
|
CDMOP Avid Bioservices, Inc.
|
205.1 million |
10.10% |
-
|
3 |
- |
-
|
CDTX Cidara Therapeutics, Inc.
|
196.4 million |
0.00% |
-
|
- |
- |
-
|
CDXS Codexis, Inc.
|
376.8 million |
0.00% |
-
|
- |
- |
-
|
CELC Celcuity Inc.
|
540.6 million |
0.00% |
-5.28
|
- |
- |
-
|
CELU Celularity Inc.
|
49.0 million |
0.00% |
-
|
- |
- |
-
|
CELUW Celularity Inc.
|
89.8 million |
0.00% |
-0.04
|
- |
- |
-
|
CELZ Creative Medical Technology Hol
|
4.2 million |
0.00% |
-0.55
|
- |
- |
-
|
CERE Cerevel Therapeutics Holdings,
|
7.5 billion |
0.00% |
-17.17
|
- |
- |
-
|
CFRX ContraFect Corporation
|
267940 |
- |
-2.36
|
- |
- |
-
|
CGEM Cullinan Therapeutics, Inc.
|
951.4 million |
0.00% |
-4.79
|
- |
- |
-
|
CGEN Compugen Ltd.
|
147.7 million |
0.00% |
55
|
- |
- |
-
|
CGTX Cognition Therapeutics, Inc.
|
17.6 million |
0.00% |
-2.87
|
- |
- |
-
|
CHRS Coherus BioSciences, Inc.
|
190.1 million |
0.00% |
-
|
- |
- |
-
|
CINC CinCor Pharma, Inc.
|
1.3 billion |
- |
-
|
- |
- |
-
|
CING Cingulate Inc.
|
12.7 million |
0.00% |
-0.04
|
- |
- |
-
|
CINGW Cingulate Inc. Warrants
|
2.0 million |
0.00% |
-0.01
|
- |
- |
-
|
CKPT Checkpoint Therapeutics, Inc.
|
205.6 million |
0.00% |
-
|
- |
- |
-
|
CLBS Caladrius Biosciences, Inc.
|
25.8 million |
- |
-2.40
|
- |
- |
-
|
CLDX Celldex Therapeutics, Inc.
|
1.7 billion |
0.00% |
-
|
- |
- |
-
|
CLGN CollPlant Biotechnologies Ltd.
|
46.5 million |
0.00% |
-
|
- |
- |
-
|
CLLS Cellectis S.A.
|
200.2 million |
0.00% |
-
|
- |
- |
-
|
CLRB Cellectar Biosciences, Inc.
|
84.2 million |
0.00% |
-1.07
|
- |
- |
-
|
CLSD Clearside Biomedical, Inc.
|
75.1 million |
0.00% |
-
|
- |
- |
-
|
CLSN Imunon, Inc.
|
13.9 million |
- |
-2.12
|
- |
- |
-
|
CLVLF Clinuvel Pharmaceuticals Ltd.
|
423.0 million |
- |
18.78
|
1 |
7 |
30%
|
CLVLY Clinuvel Pharmaceuticals Ltd.
|
422.5 million |
0.59% |
18.76
|
1 |
7 |
20%
|
CLVS Clovis Oncology, Inc.
|
34.8 million |
0.92% |
-1.42
|
- |
- |
-
|
CLXT Calyxt, Inc.
|
31.3 million |
- |
-3.73
|
- |
- |
-
|
CMMB Chemomab Therapeutics Ltd.
|
31.9 million |
0.00% |
-0.20
|
- |
- |
-
|
CMPI Checkmate Pharmaceuticals, Inc.
|
227.1 million |
- |
-
|
- |
- |
-
|
CMRX Chimerix, Inc.
|
89.6 million |
0.00% |
-
|
- |
- |
-
|
CMXHF CSL LTD
|
87.7 billion |
1.34% |
31.26
|
2 |
21 |
0%
|
CNCE Concert Pharmaceuticals, Inc.
|
403.4 million |
- |
-4.28
|
- |
- |
-
|
CNSP CNS Pharmaceuticals, Inc.
|
5.9 million |
0.00% |
-0.04
|
- |
- |
-
|
CNST Constellation Pharmaceuticals, Inc.
|
1.6 billion |
- |
-7.75
|
- |
- |
-
|
CNTA Centessa Pharmaceuticals plc
|
2.3 billion |
0.00% |
-6.56
|
- |
- |
-
|
CNTB Connect Biopharma Holdings Limi
|
55.8 million |
0.00% |
-0.73
|
- |
- |
-
|
COCP Cocrystal Pharma, Inc.
|
22.4 million |
0.00% |
-0.79
|
- |
- |
-
|
COGT Cogent Biosciences, Inc.
|
1.0 billion |
0.00% |
-2.44
|
- |
- |
-
|
CONCORDBIO.BO Concord Biotech Limited
|
2.7 billion |
0.00% |
69.80
|
- |
- |
-
|
CONCORDBIO.NS Concord Biotech Limited
|
2.7 billion |
0.00% |
69.81
|
- |
1 |
-
|
CORT Corcept Therapeutics Incorporat
|
5.9 billion |
0.00% |
44.80
|
- |
- |
-
|
COYA Coya Therapeutics, Inc.
|
99.9 million |
0.00% |
-
|
- |
- |
-
|
CPRX Catalyst Pharmaceuticals, Inc.
|
2.6 billion |
0.00% |
18.40
|
- |
- |
-
|
CRBP Corbus Pharmaceuticals Holdings
|
185.9 million |
0.00% |
-2.35
|
- |
- |
-
|
CRBU Caribou Biosciences, Inc.
|
184.3 million |
0.00% |
-
|
- |
- |
-
|
CRDF Cardiff Oncology, Inc.
|
118.1 million |
0.00% |
-
|
- |
- |
-
|
CRIS Curis, Inc.
|
32.7 million |
0.00% |
-
|
- |
- |
-
|
CRMD CorMedix Inc.
|
667.4 million |
0.00% |
-
|
- |
- |
-
|
CRNX Crinetics Pharmaceuticals, Inc.
|
5.5 billion |
0.00% |
-
|
- |
- |
-
|
CRSP CRISPR Therapeutics AG
|
4.3 billion |
0.00% |
-
|
- |
- |
-
|
CRTX Cortexyme, Inc.
|
58.3 million |
- |
-20.13
|
- |
- |
-
|
CRVS Corvus Pharmaceuticals, Inc.
|
530.8 million |
0.00% |
-3.23
|
- |
- |
-
|
CSBR Champions Oncology, Inc.
|
62.7 million |
0.00% |
-
|
- |
- |
-
|
CSL.AX CSL FPO [CSL]
|
87.7 billion |
0.94% |
33.10
|
2 |
31 |
9%
|
CSLLY CSL Ltd.
|
88.3 billion |
2.87% |
33.46
|
2 |
16 |
6%
|
CTIC CTI BioPharma Corp.
|
646.2 million |
- |
-3.92
|
- |
- |
-
|
CTMX CytomX Therapeutics, Inc.
|
98.6 million |
0.00% |
7.88
|
- |
- |
-
|
CTNM Contineum Therapeutics, Inc. Class A Common Stock
|
369.4 million |
- |
-39.81
|
- |
- |
-
|
CTXR Citius Pharmaceuticals, Inc.
|
36.1 million |
0.00% |
-
|
- |
- |
-
|
CUE Cue Biopharma, Inc.
|
72.2 million |
0.00% |
-
|
- |
- |
-
|
CUV.AX CLINUVEL FPO [CUV]
|
416.6 million |
0.00% |
18.78
|
- |
7 |
22%
|
CVAC CureVac N.V.
|
639.4 million |
0.00% |
5.70
|
- |
- |
-
|
CVM Cel-Sci Corporation
|
44.4 million |
0.00% |
-3.31
|
- |
- |
-
|
CWBR CohBar Inc.
|
1.4 million |
0.00% |
-0.20
|
- |
- |
-
|
CYAD Celyad Oncology SA
|
16.4 million |
- |
-3.91
|
- |
- |
-
|
CYBN Cybin Inc.
|
211.3 million |
0.00% |
-1.83
|
- |
- |
-
|
CYCC Cyclacel Pharmaceuticals, Inc.
|
804522 |
0.00% |
-
|
- |
- |
-
|
CYCCP Cyclacel Pharmaceuticals, Inc.
|
2.1 million |
6.15% |
-9.72
|
4 |
11 |
-
|
CYCN Cyclerion Therapeutics, Inc.
|
11.3 million |
0.00% |
-0.20
|
- |
- |
-
|
CYT Cyteir Therapeutics, Inc.
|
108.7 million |
0.00% |
-3.38
|
4 |
- |
-
|
CYTK Cytokinetics, Incorporated
|
6.1 billion |
0.00% |
-
|
- |
- |
-
|
CYTO Altamira Therapeutics Ltd.
|
2.0 million |
0.00% |
0.28
|
- |
- |
-
|
CYTR LadRx Corporation
|
4.1 million |
- |
-2.19
|
- |
- |
-
|
CZO.V Ceapro Inc
|
16.2 million |
0.00% |
-5.83
|
- |
- |
-
|
DARE Dare Bioscience, Inc.
|
29.2 million |
0.00% |
-
|
- |
- |
-
|
DAWN Day One Biopharmaceuticals, Inc
|
1.6 billion |
0.00% |
-
|
- |
- |
-
|
DBTX Decibel Therapeutics, Inc.
|
84.3 million |
- |
-
|
- |
- |
-
|
DBVT DBV Technologies S.A.
|
70.4 million |
0.00% |
-
|
- |
- |
-
|
DFFN Diffusion Pharmaceuticals Inc.
|
7.8 million |
- |
-2.01
|
- |
- |
-
|
DICE DICE Therapeutics, Inc.
|
1.6 billion |
- |
11.66
|
- |
- |
-
|
DMAC DiaMedica Therapeutics Inc.
|
229.6 million |
0.00% |
-4.91
|
- |
- |
-
|
DNA Ginkgo Bioworks Holdings, Inc.
|
547.2 million |
0.00% |
-
|
- |
- |
-
|
DNLI Denali Therapeutics Inc.
|
3.6 billion |
0.00% |
-
|
- |
- |
-
|
DRMA Dermata Therapeutics, Inc.
|
2.9 million |
0.00% |
-0.10
|
- |
- |
-
|
DRMAW Dermata Therapeutics, Inc. Warrant
|
1.3 million |
0.00% |
-0.01
|
- |
- |
-
|
DRNA Dicerna Pharmaceuticals, Inc.
|
2.9 billion |
- |
-14.22
|
- |
- |
-
|
DRUG Bright Minds Biosciences Inc.
|
278.3 million |
0.00% |
-1.30
|
- |
- |
-
|
DSGN Design Therapeutics, Inc.
|
362.9 million |
0.00% |
-1.78
|
- |
- |
-
|
DTIL Precision BioSciences, Inc.
|
46.0 million |
0.00% |
15
|
- |
- |
-
|
DYAI Dyadic International, Inc.
|
33.6 million |
0.00% |
-
|
- |
- |
-
|
DYN Dyne Therapeutics, Inc.
|
2.9 billion |
0.00% |
-6.38
|
4 |
- |
-
|
EARS Auris Medical Holding Ltd.
|
39.2 million |
3.88% |
-0.56
|
- |
- |
-
|
EDIT Editas Medicine, Inc.
|
180.8 million |
0.00% |
-
|
- |
- |
-
|
EDSA Edesa Biotech, Inc.
|
7.3 million |
0.00% |
-0.24
|
- |
- |
-
|
EFTR eFFECTOR Therapeutics, Inc.
|
941 |
0.00% |
-0.65
|
- |
- |
-
|
EFTRW eFFECTOR Therapeutics, Inc.
|
23.4 million |
0.00% |
-0.12
|
- |
- |
-
|
EIGR Eiger BioPharmaceuticals, Inc.
|
2.6 million |
0.00% |
-0.10
|
- |
- |
-
|
ELDN Eledon Pharmaceuticals, Inc.
|
288.5 million |
0.00% |
10.73
|
- |
- |
-
|
ELEV Elevation Oncology, Inc.
|
35.0 million |
0.00% |
-1.43
|
- |
- |
-
|
ELOX Eloxx Pharmaceuticals, Inc.
|
314 |
0.00% |
-0.10
|
- |
- |
-
|
ELVN Enliven Therapeutics, Inc.
|
1.2 billion |
0.00% |
-12.49
|
- |
- |
-
|
ELYM Eliem Therapeutics, Inc
|
342.7 million |
0.00% |
-1.85
|
- |
- |
-
|
EMMA Emmaus Life Sciences, Inc.
|
1.1 million |
0.00% |
-1.25
|
- |
- |
-
|
ENLV Enlivex Therapeutics Ltd.
|
26.8 million |
0.00% |
-2.18
|
- |
- |
-
|
ENOB Enochian Biosciences Inc.
|
72.4 million |
- |
-14.56
|
- |
- |
-
|
ENSC Ensysce Biosciences, Inc.
|
13.3 million |
0.00% |
-
|
- |
- |
-
|
ENTA Enanta Pharmaceuticals, Inc.
|
182.3 million |
0.00% |
-
|
- |
- |
-
|
ENTX Entera Bio Ltd.
|
65.9 million |
0.00% |
-
|
- |
- |
-
|
ENVB Enveric Biosciences, Inc.
|
3.6 million |
0.00% |
-0.07
|
- |
- |
-
|
ENZN Enzon Pharmaceuticals, Inc.
|
5.9 million |
0.00% |
11
|
1 |
- |
-
|
EPIX ESSA Pharma Inc.
|
75.5 million |
0.00% |
-16.33
|
- |
- |
-
|
EPZM Epizyme, Inc.
|
247.5 million |
1.66% |
-5.27
|
- |
- |
-
|
EQ Equillium, Inc.
|
25.1 million |
0.00% |
-
|
- |
- |
-
|
EQRX EQRx, Inc.
|
1.2 billion |
- |
-
|
- |
- |
-
|
EQRXW EQRx, Inc.
|
- |
- |
-
|
- |
- |
-
|
ERAS Erasca, Inc.
|
856.7 million |
0.00% |
-1.02
|
- |
- |
-
|
ERYP PHAXIAM Therapeutics S.A.
|
23.9 million |
- |
-1.86
|
- |
- |
-
|
ETNB 89bio, Inc.
|
948.9 million |
0.00% |
-
|
- |
- |
-
|
ETTX Entasis Therapeutics Holdings Inc.
|
104.3 million |
- |
-0.51
|
- |
- |
-
|
EVAX Evaxion Biotech A/S
|
7.5 million |
0.00% |
-
|
- |
- |
-
|
EVFM Evofem Biosciences, Inc.
|
1.0 million |
0.00% |
0.00
|
- |
- |
-
|
EVFMD Evofem Biosciences, Inc.
|
- |
- |
-
|
- |
- |
-
|
EVGN Evogene Ltd.
|
9.9 million |
0.00% |
-
|
- |
- |
-
|
EVLO Evelo Biosciences, Inc.
|
5694 |
0.00% |
-1.81
|
- |
- |
-
|
EWTX Edgewise Therapeutics, Inc.
|
2.7 billion |
0.00% |
-14.02
|
- |
- |
-
|
EXAI Exscientia Plc
|
733.9 million |
0.00% |
-
|
- |
- |
-
|
EXEL Exelixis, Inc.
|
10.3 billion |
0.00% |
23.10
|
- |
- |
-
|
EYEG EyeGate Pharmaceuticals, Inc.
|
13.8 million |
- |
-1.72
|
- |
- |
-
|
EYEN Eyenovia, Inc.
|
9.6 million |
0.00% |
-
|
- |
- |
-
|
EYPT EyePoint Pharmaceuticals, Inc.
|
594.5 million |
0.00% |
-
|
- |
- |
-
|
EZZ.AX EZZ LIFE FPO [EZZ]
|
78.3 million |
0.00% |
16.50
|
2 |
4 |
30%
|
FATE Fate Therapeutics, Inc.
|
301.8 million |
0.00% |
-
|
- |
- |
-
|
FBIO Fortress Biotech, Inc.
|
60.2 million |
0.00% |
-
|
- |
- |
-
|
FBIOP Fortress Biotech, Inc. - 9.375%
|
35.1 million |
0.00% |
-15.64
|
12 |
8 |
0%
|
FBRX Forte Biosciences, Inc.
|
35.1 million |
0.00% |
-0.52
|
- |
- |
-
|
FDMT 4D Molecular Therapeutics, Inc.
|
400.8 million |
0.00% |
-
|
- |
- |
-
|
FENC Fennec Pharmaceuticals Inc.
|
116.6 million |
0.00% |
60.43
|
- |
- |
-
|
FERMENTA.BO FERMENTA BIOTECH LIMITED
|
141.4 million |
- |
-
|
- |
- |
-
|
FGEN FibroGen, Inc
|
33.7 million |
0.00% |
-
|
- |
- |
-
|
FHTX Foghorn Therapeutics Inc.
|
365.2 million |
0.00% |
-
|
- |
- |
-
|
FIXX Homology Medicines, Inc.
|
51.9 million |
0.00% |
-0.31
|
- |
- |
-
|
FMTX Forma Therapeutics Holdings, Inc.
|
998.7 million |
- |
-
|
- |
- |
-
|
FNCH Finch Therapeutics Group, Inc.
|
18.1 million |
0.00% |
-0.04
|
- |
- |
-
|
FOLD Amicus Therapeutics, Inc.
|
2.9 billion |
0.00% |
-
|
- |
- |
-
|
FREQ Frequency Therapeutics, Inc.
|
10.9 million |
- |
-42.89
|
- |
- |
-
|
FRLN Freeline Therapeutics Holdings plc
|
28.2 million |
0.00% |
-0.56
|
- |
- |
-
|
FSTX F-star Therapeutics, Inc.
|
156.5 million |
- |
-
|
- |
- |
-
|
FULC Fulcrum Therapeutics, Inc.
|
215.2 million |
0.00% |
-
|
- |
- |
-
|
FUSN Fusion Pharmaceuticals Inc.
|
1.8 billion |
0.00% |
-6.94
|
- |
- |
-
|
FWBI First Wave BioPharma, Inc.
|
5.8 million |
0.00% |
0.00
|
- |
- |
-
|
FWP Forward Pharma A/S
|
20.5 million |
1393.21% |
-7.66
|
- |
- |
-
|
GALT Galectin Therapeutics Inc.
|
128.3 million |
0.00% |
-2.28
|
- |
- |
-
|
GANX Gain Therapeutics, Inc.
|
47.1 million |
0.00% |
-
|
- |
- |
-
|
GBIM GlobeImmune, Inc.
|
2.0 million |
- |
-0.27
|
- |
- |
-
|
GBIO Generation Bio Co.
|
145.6 million |
0.00% |
-
|
- |
- |
-
|
GBT Global Blood Therapeutics, Inc.
|
4.6 billion |
- |
-9.31
|
- |
- |
-
|
GENSF Genus plc
|
1.9 billion |
1.39% |
44.29
|
2 |
13 |
4%
|
GENSY GENUS UNSPON ADR EA REPR 1 ORD
|
1.5 billion |
- |
-
|
- |
1 |
-
|
GERN Geron Corporation
|
2.3 billion |
0.00% |
-
|
- |
- |
-
|
GHRS GH Research PLC
|
416.2 million |
0.00% |
-10.13
|
- |
- |
-
|
GLMD Galmed Pharmaceuticals Ltd.
|
4.6 million |
0.00% |
0.04
|
- |
- |
-
|
GLPG Galapagos NV
|
1.8 billion |
0.00% |
-
|
- |
- |
-
|
GLPG.AS GALAPAGOS
|
1.8 billion |
0.00% |
-
|
- |
- |
-
|
GLSI Greenwich LifeSciences, Inc.
|
194.0 million |
0.00% |
-12.07
|
- |
- |
-
|
GLTO Galecto, Inc.
|
9.3 million |
0.00% |
-0.38
|
- |
- |
-
|
GLUE Monte Rosa Therapeutics, Inc.
|
216.9 million |
- |
-1.61
|
- |
- |
-
|
GLYC GlycoMimetics, Inc.
|
25.8 million |
0.00% |
-5.08
|
- |
- |
-
|
GMAB Genmab A/S
|
14.7 billion |
0.00% |
22.31
|
- |
- |
-
|
GMDA Gamida Cell Ltd.
|
4.3 million |
0.00% |
-0.47
|
- |
- |
-
|
GMTX Gemini Therapeutics, Inc.
|
71.1 million |
- |
-
|
- |
- |
-
|
GNCA Genocea Biosciences, Inc.
|
396373 |
- |
-1.64
|
- |
- |
-
|
GNFT GENFIT S.A.
|
289.1 million |
0.00% |
13.09
|
- |
- |
-
|
GNPX Genprex, Inc.
|
9.4 million |
0.00% |
-0.18
|
- |
- |
-
|
GNS.L GENUS PLC ORD 10P
|
16.1 million |
0.02% |
155
|
2 |
24 |
3%
|
GNTA Genenta Science S.p.A.
|
88.9 million |
0.00% |
-4.57
|
- |
- |
-
|
GOSS Gossamer Bio, Inc.
|
158.8 million |
0.00% |
-
|
- |
- |
-
|
GOVX GeoVax Labs, Inc.
|
20.7 million |
0.00% |
-
|
- |
- |
-
|
GOVXW GeoVax Labs, Inc.
|
7.0 million |
0.00% |
-
|
- |
- |
-
|
GRAY Graybug Vision, Inc.
|
121.0 million |
- |
-
|
- |
- |
-
|
GRCL Gracell Biotechnologies Inc.
|
989.9 million |
0.00% |
-10.59
|
- |
- |
-
|
GRI GRI Bio, Inc.
|
3.3 million |
0.00% |
0.02
|
4 |
- |
-
|
GRPH Graphite Bio, Inc.
|
189.8 million |
0.00% |
-1.37
|
- |
- |
-
|
GRTS Gritstone bio, Inc.
|
3.8 million |
0.00% |
-
|
- |
- |
-
|
GRTX Galera Therapeutics, Inc.
|
1.9 million |
0.00% |
-0.09
|
- |
- |
-
|
GTBP GT Biopharma, Inc.
|
6.7 million |
0.00% |
-0.54
|
- |
- |
-
|
GTHX G1 Therapeutics, Inc.
|
377.2 million |
0.00% |
-
|
- |
- |
-
|
HALO Halozyme Therapeutics, Inc.
|
7.8 billion |
0.00% |
20.19
|
- |
- |
-
|
HARP Harpoon Therapeutics, Inc.
|
492.3 million |
0.00% |
-14.67
|
- |
- |
-
|
HCWB HCW Biologics Inc.
|
18.7 million |
0.00% |
-2
|
- |
- |
-
|
HEPA Hepion Pharmaceuticals, Inc.
|
4.3 million |
0.00% |
-0.15
|
- |
- |
-
|
HGEN Humanigen, Inc.
|
23816 |
- |
-5.60
|
- |
- |
-
|
HILS Hillstream BioPharma, Inc.
|
4.9 million |
- |
-
|
- |
- |
-
|
HOOK HOOKIPA Pharma Inc.
|
30.7 million |
0.00% |
-
|
- |
- |
-
|
HOTH Hoth Therapeutics, Inc.
|
5.8 million |
0.00% |
-0.29
|
- |
- |
-
|
HRMY Harmony Biosciences Holdings, I
|
1.9 billion |
0.00% |
16
|
- |
- |
-
|
HRTX Heron Therapeutics, Inc.
|
246.4 million |
0.00% |
-
|
- |
- |
-
|
HSTO Histogen Inc.
|
897069 |
0.00% |
-0.12
|
- |
- |
-
|
HTBX Heat Biologics, Inc.
|
81.8 million |
4.65% |
-3.29
|
- |
- |
-
|
HUMA Humacyte, Inc.
|
621.5 million |
0.00% |
-4.17
|
- |
- |
-
|
HUMAW Humacyte, Inc.
|
385.7 million |
0.00% |
-0.17
|
- |
- |
-
|
HURA TuHURA Biosciences, Inc.
|
229.2 million |
0.00% |
-14.65
|
- |
- |
-
|
HVO.L HVIVO PLC ORD 0.1P
|
1.8 million |
0.00% |
7.10
|
- |
2 |
-
|
IBIO iBio, Inc.
|
23.3 million |
0.00% |
-0.03
|
- |
- |
-
|
IBRX ImmunityBio, Inc.
|
3.3 billion |
0.00% |
-
|
- |
- |
-
|
IBT.L INTERNATIONAL BIOTECHNOLOGY TRU
|
3.2 million |
0.04% |
6.86
|
2 |
8 |
30%
|
ICCC ImmuCell Corporation
|
43.1 million |
0.00% |
-
|
- |
- |
-
|
ICPT Intercept Pharmaceuticals, Inc.
|
794.7 million |
- |
-5.82
|
- |
- |
-
|
IDRA Idera Pharmaceuticals, Inc.
|
18.7 million |
- |
-0.31
|
- |
- |
-
|
IDYA IDEAYA Biosciences, Inc.
|
2.3 billion |
0.00% |
-
|
- |
- |
-
|
IFRX InflaRx N.V.
|
119.5 million |
0.00% |
-
|
- |
- |
-
|
IGC IGC Pharma, Inc.
|
28.6 million |
0.00% |
-
|
- |
- |
-
|
IGMS IGM Biosciences, Inc.
|
563.1 million |
0.00% |
-
|
- |
- |
-
|
IKNA Ikena Oncology, Inc.
|
84.9 million |
0.00% |
-
|
- |
- |
-
|
IKT Inhibikase Therapeutics, Inc.
|
183.4 million |
0.00% |
-0.75
|
- |
- |
-
|
IMAB I-MAB
|
85.2 million |
0.00% |
-0.46
|
- |
- |
-
|
IMCR Immunocore Holdings plc
|
1.6 billion |
0.00% |
-
|
- |
- |
-
|
IMGN ImmunoGen, Inc.
|
8.7 billion |
0.00% |
-111.54
|
- |
- |
-
|
IMGO Imago BioSciences, Inc.
|
1.2 billion |
- |
-
|
- |
- |
-
|
IMMP Immutep Limited
|
309.9 million |
0.00% |
-
|
- |
- |
-
|
IMMX Immix Biopharma, Inc.
|
69.9 million |
0.00% |
-3.08
|
- |
- |
-
|
IMNM Immunome, Inc.
|
618.2 million |
0.00% |
-
|
- |
- |
-
|
IMPL Impel Pharmaceuticals Inc.
|
8.8 million |
- |
-
|
- |
- |
-
|
IMRA IMARA Inc.
|
165.8 million |
- |
105.33
|
- |
- |
-
|
IMRN Immuron Limited
|
11.8 million |
0.00% |
-3.98
|
- |
- |
-
|
IMTX Immatics N.V.
|
954.2 million |
0.00% |
-
|
- |
- |
-
|
IMTXW Immatics N.V.
|
673.0 million |
0.00% |
-
|
- |
- |
-
|
IMU.AX IMUGENE FPO [IMU]
|
184.6 million |
0.00% |
-10.20
|
- |
- |
-
|
IMUX Immunic, Inc.
|
105.4 million |
0.00% |
-
|
- |
- |
-
|
IMV IMV Inc.
|
9.7 million |
- |
-7.90
|
- |
- |
-
|
IMVT Immunovant, Inc.
|
4.2 billion |
0.00% |
-17.82
|
- |
- |
-
|
INBX Inhibrx Biosciences, Inc.
|
231.6 million |
0.00% |
0.13
|
- |
- |
-
|
INCY Incyte Corporation
|
14.4 billion |
0.00% |
829.11
|
- |
- |
-
|
INDP Indaptus Therapeutics, Inc.
|
12.3 million |
0.00% |
-0.91
|
- |
- |
-
|
INFI I:SPX Oct 2023 Weekly 3100.000
|
17.9 million |
- |
-4.52
|
- |
- |
-
|
INKT MiNK Therapeutics, Inc.
|
26.8 million |
0.00% |
-1.25
|
- |
- |
-
|
INM InMed Pharmaceuticals Inc.
|
3.1 million |
0.00% |
0.02
|
- |
- |
-
|
INMB INmune Bio Inc.
|
108.6 million |
0.00% |
-
|
- |
- |
-
|
INO Inovio Pharmaceuticals, Inc.
|
109.6 million |
0.00% |
-
|
- |
- |
-
|
INSM Insmed Incorporated
|
13.5 billion |
0.00% |
-
|
- |
- |
-
|
INVA Innoviva, Inc.
|
1.3 billion |
0.00% |
25.13
|
3 |
- |
-
|
INZY Inozyme Pharma, Inc.
|
165.1 million |
0.00% |
-3.69
|
- |
- |
-
|
IOBT IO Biotech, Inc.
|
56.7 million |
0.00% |
-0.70
|
- |
- |
-
|
IONS Ionis Pharmaceuticals, Inc.
|
5.6 billion |
0.00% |
-
|
- |
- |
-
|
IOVA Iovance Biotherapeutics, Inc.
|
2.8 billion |
0.00% |
-
|
- |
- |
-
|
IPA ImmunoPrecise Antibodies Ltd.
|
11.0 million |
0.00% |
-
|
- |
- |
-
|
IP.BK IP_INTER PHARMA
|
59.7 million |
0.00% |
168
|
1 |
2 |
-
|
IPHA Innate Pharma S.A.
|
145.7 million |
0.00% |
-3.06
|
- |
- |
-
|
IPSC Century Therapeutics, Inc.
|
113.1 million |
0.00% |
-
|
- |
- |
-
|
ISEE IVERIC bio, Inc.
|
5.5 billion |
- |
-4.87
|
- |
- |
-
|
ITECH.ST I-Tech AB
|
54.8 million |
0.02% |
23.81
|
- |
- |
-
|
ITOS iTeos Therapeutics, Inc.
|
300.3 million |
0.00% |
-
|
- |
- |
-
|
ITRM Iterum Therapeutics plc
|
74.3 million |
0.00% |
-0.65
|
- |
- |
-
|
IVA Inventiva S.A. - American Depos
|
217.7 million |
0.00% |
-1.76
|
- |
- |
-
|
IXC.AX INVEX THER FPO [IXC]
|
3.2 million |
0.00% |
-0.82
|
- |
1 |
-
|
JAGX Jaguar Health, Inc.
|
11.3 million |
0.00% |
0.05
|
- |
- |
-
|
JANX Janux Therapeutics, Inc.
|
3.5 billion |
0.00% |
-
|
- |
- |
-
|
JAZZ Jazz Pharmaceuticals plc
|
7.4 billion |
0.00% |
17.36
|
- |
- |
-
|
JNCE Jounce Therapeutics, Inc.
|
101.6 million |
- |
-2.45
|
- |
- |
-
|
JUNS Jupiter Neurosciences, Inc. Common Stock
|
180.5 million |
- |
-12.45
|
- |
- |
-
|
KALA KALA BIO, Inc.
|
29.8 million |
0.00% |
-0.33
|
- |
- |
-
|
KALV KalVista Pharmaceuticals, Inc.
|
514.3 million |
0.00% |
-5.02
|
- |
- |
-
|
KDMN Kadmon Holdings, Inc.
|
1.6 billion |
- |
-13.43
|
- |
- |
-
|
KDNY Chinook Therapeutics, Inc.
|
1.5 billion |
- |
-2.01
|
- |
- |
-
|
KLDO Kaleido Biosciences, Inc.
|
4262 |
- |
-
|
- |
- |
-
|
KMPH KemPharm, Inc.
|
200.5 million |
- |
17.60
|
- |
- |
-
|
KNTE Kinnate Biopharma Inc.
|
125.0 million |
0.00% |
-0.84
|
- |
- |
-
|
KOD Kodiak Sciences Inc
|
267.3 million |
0.00% |
-0.78
|
- |
- |
-
|
KPRX Kiora Pharmaceuticals, Inc.
|
10.5 million |
0.00% |
3.33
|
- |
- |
-
|
KPTI Karyopharm Therapeutics Inc.
|
96.3 million |
0.00% |
-
|
- |
- |
-
|
KRBP Kiromic BioPharma, Inc.
|
1.5 million |
0.00% |
-0.07
|
- |
- |
-
|
KRON Kronos Bio, Inc.
|
61.5 million |
0.00% |
-
|
- |
- |
-
|
KROS Keros Therapeutics, Inc.
|
2.7 billion |
0.00% |
-11.92
|
- |
- |
-
|
KRTX Karuna Therapeutics, Inc.
|
12.6 billion |
0.00% |
-29.07
|
- |
- |
-
|
KRYS Krystal Biotech, Inc.
|
5.4 billion |
0.00% |
105.32
|
- |
- |
-
|
KTRA Kintara Therapeutics, Inc.
|
10.5 million |
0.00% |
-0.01
|
- |
- |
-
|
KTTA Pasithea Therapeutics Corp.
|
3.7 million |
0.00% |
-0.50
|
- |
- |
-
|
KTTAW Pasithea Therapeutics Corp. Warrant
|
11.2 million |
0.00% |
-
|
- |
- |
-
|
KURA Kura Oncology, Inc.
|
833.6 million |
0.00% |
-10.46
|
- |
- |
-
|
KYMR Kymera Therapeutics, Inc.
|
2.7 billion |
0.00% |
-
|
- |
- |
-
|
KZIA Kazia Therapeutics Limited
|
19.1 million |
0.00% |
-0.37
|
- |
- |
-
|
KZR Kezar Life Sciences, Inc.
|
53.8 million |
0.00% |
-
|
- |
- |
-
|
LABP Landos Biopharma, Inc.
|
69.4 million |
0.00% |
-1.37
|
- |
- |
-
|
LBPH Longboard Pharmaceuticals, Inc.
|
2.3 billion |
0.00% |
-8.09
|
- |
- |
-
|
LBPS 4D pharma plc
|
37.2 million |
- |
-
|
- |
- |
-
|
LCTX Lineage Cell Therapeutics, Inc.
|
129.1 million |
0.00% |
-
|
- |
- |
-
|
LEGN Legend Biotech Corporation
|
7.0 billion |
0.00% |
-
|
- |
- |
-
|
LENZ LENZ Therapeutics, Inc.
|
1.0 billion |
0.00% |
-13.64
|
- |
1 |
-
|
LEXX Lexaria Bioscience Corp.
|
36.5 million |
0.00% |
-
|
- |
- |
-
|
LGND Ligand Pharmaceuticals Incorpor
|
2.3 billion |
0.00% |
49.03
|
- |
- |
-
|
LIAN LianBio
|
34.5 million |
0.00% |
-4.99
|
- |
1 |
-
|
LIFE aTyr Pharma, Inc.
|
131.1 million |
0.00% |
-1.77
|
- |
- |
-
|
LIXT Lixte Biotechnology Holdings, I
|
4.5 million |
0.00% |
-0.64
|
- |
- |
-
|
LIXTW Lixte Biotechnology Holdings, I
|
39.5 million |
0.00% |
-
|
- |
- |
-
|
LJPC La Jolla Pharmaceutical Company
|
171.2 million |
0.00% |
38.78
|
- |
- |
-
|
LMNL Liminal BioSciences Inc.
|
21.0 million |
- |
0.71
|
- |
- |
-
|
LOGC LogicBio Therapeutics, Inc.
|
68.2 million |
- |
-3.94
|
- |
- |
-
|
LPCN Lipocine Inc.
|
27.3 million |
0.00% |
-
|
- |
- |
-
|
LPTX Leap Therapeutics, Inc.
|
124.0 million |
0.00% |
-0.73
|
- |
- |
-
|
LQDA Liquidia Corporation
|
938.6 million |
0.00% |
-
|
- |
- |
-
|
LRMR Larimar Therapeutics, Inc.
|
387.3 million |
0.00% |
-10.25
|
- |
- |
-
|
LTRN Lantern Pharma Inc.
|
37.6 million |
0.00% |
-3.04
|
- |
- |
-
|
LUMO Lumos Pharma, Inc.
|
37.7 million |
0.00% |
-
|
- |
- |
-
|
LVTX LAVA Therapeutics N.V.
|
40.9 million |
0.00% |
-
|
- |
- |
-
|
LXRX Lexicon Pharmaceuticals, Inc.
|
352.5 million |
0.00% |
-
|
- |
- |
-
|
LYEL Lyell Immunopharma, Inc.
|
307.1 million |
0.00% |
-2.25
|
- |
- |
-
|
LYRA Lyra Therapeutics, Inc.
|
13.8 million |
0.00% |
-
|
- |
- |
-
|
MACK Merrimack Pharmaceuticals, Inc.
|
218.4 million |
0.00% |
-138
|
- |
- |
-
|
MAGLE.ST Magle Chemoswed Holding AB
|
57.8 million |
0.01% |
20.51
|
- |
- |
-
|
MAIA MAIA Biotechnology, Inc.
|
63.0 million |
0.00% |
-1.08
|
- |
- |
-
|
MBIO Mustang Bio, Inc.
|
9.1 million |
0.00% |
-0.15
|
- |
- |
-
|
MBRX Moleculin Biotech, Inc.
|
7.9 million |
0.00% |
-0.56
|
- |
- |
-
|
MBX MBX Biosciences, Inc. Common Stock
|
634.1 million |
0.00% |
-11.52
|
- |
- |
-
|
MCRB Seres Therapeutics, Inc.
|
139.1 million |
0.00% |
-
|
- |
- |
-
|
MDGL Madrigal Pharmaceuticals, Inc.
|
7.3 billion |
0.00% |
-
|
- |
- |
-
|
MDNA Medicenna Therapeutics Corp.
|
11.2 million |
- |
-18.44
|
- |
- |
-
|
MDWD MediWound Ltd.
|
183.1 million |
0.00% |
-
|
- |
- |
-
|
MDXG MiMedx Group, Inc
|
1.1 billion |
0.00% |
13.11
|
- |
- |
-
|
MEIP MEI Pharma, Inc.
|
17.7 million |
0.00% |
1.14
|
- |
- |
-
|
MESO Mesoblast Limited
|
1.3 billion |
0.00% |
-2.20
|
- |
- |
-
|
MGNX MacroGenics, Inc.
|
236.6 million |
0.00% |
-
|
- |
- |
-
|
MGTA Magenta Therapeutics, Inc. Common Stock
|
44.2 million |
- |
-3.45
|
- |
- |
-
|
MGTX MeiraGTx Holdings plc
|
476.0 million |
0.00% |
-
|
- |
- |
-
|
MIRM Mirum Pharmaceuticals, Inc.
|
2.2 billion |
0.00% |
-
|
- |
- |
-
|
MIRO Miromatrix Medical Inc.
|
93.0 million |
- |
-
|
- |
- |
-
|
MIST Milestone Pharmaceuticals Inc.
|
99.7 million |
0.00% |
-1.13
|
- |
- |
-
|
MITO Stealth BioTherapeutics Corp
|
18.4 million |
- |
-2.07
|
- |
- |
-
|
MLND Millendo Therapeutics, Inc.
|
20.2 million |
- |
-0.64
|
- |
- |
-
|
MNKD MannKind Corporation
|
1.9 billion |
0.00% |
85.94
|
- |
- |
-
|
MNMD Mind Medicine (MindMed) Inc.
|
657.8 million |
0.00% |
-2.36
|
- |
- |
-
|
MNOV MediciNova, Inc.
|
111.4 million |
0.00% |
-7.32
|
- |
- |
-
|
MNPR Monopar Therapeutics Inc.
|
89.1 million |
0.00% |
-0.51
|
- |
- |
-
|
MOLN Molecular Partners AG
|
212.0 million |
0.00% |
-
|
- |
- |
-
|
MOR MorphoSys AG
|
2.9 billion |
0.00% |
-
|
- |
- |
-
|
MORF Morphic Holding, Inc.
|
2.9 billion |
0.00% |
-10.56
|
- |
- |
-
|
MREO Mereo BioPharma Group plc
|
584.9 million |
0.00% |
-12.16
|
- |
- |
-
|
MRKR Marker Therapeutics, Inc.
|
30.7 million |
0.00% |
-
|
- |
- |
-
|
MRNA Moderna, Inc.
|
16.5 billion |
0.00% |
-
|
- |
- |
-
|
MRNS Marinus Pharmaceuticals, Inc.
|
15.9 million |
0.00% |
-
|
- |
- |
-
|
MRSN Mersana Therapeutics, Inc.
|
315.0 million |
0.00% |
-
|
- |
- |
-
|
MRTX Mirati Therapeutics, Inc.
|
4.2 billion |
- |
-4.71
|
- |
- |
-
|
MRUS Merus N.V.
|
3.0 billion |
0.00% |
-
|
- |
- |
-
|
MRVI Maravai LifeSciences Holdings,
|
1.4 billion |
0.00% |
-
|
- |
- |
-
|
MTCR Metacrine, Inc.
|
25.5 million |
- |
-
|
- |
1 |
-
|
MTEM Molecular Templates, Inc.
|
3.1 million |
0.00% |
-
|
- |
- |
-
|
MTNB Matinas Biopharma Holdings, Inc
|
4.5 million |
0.00% |
-2.08
|
- |
- |
-
|
MTP Midatech Pharma PLC
|
2.0 million |
0.00% |
-0.34
|
- |
- |
-
|
MYMD MyMD Pharmaceuticals, Inc.
|
4.5 million |
0.00% |
-0.82
|
- |
- |
-
|
MYMX Mymetics Corporation
|
334134 |
0.34% |
-0.02
|
- |
- |
-
|
MYOV Myovant Sciences Ltd.
|
2.6 billion |
- |
-7.04
|
- |
- |
-
|
NAUT Nautilus Biotechnology, Inc.
|
268.7 million |
0.00% |
-5.87
|
- |
- |
-
|
NAVB Navidea Biopharmaceuticals, Inc
|
3.5 million |
0.00% |
-0.17
|
- |
- |
-
|
NBRV Nabriva Therapeutics plc
|
6.0 million |
- |
-0.62
|
- |
- |
-
|
NBSE NeuBase Therapeutics, Inc.
|
1.4 million |
0.00% |
-0.04
|
- |
- |
-
|
NBTX Nanobiotix S.A.
|
148.6 million |
0.00% |
-3.96
|
- |
- |
-
|
NBY NovaBay Pharmaceuticals, Inc.
|
3.5 million |
0.00% |
-
|
- |
- |
-
|
NCNA NuCana plc
|
5.2 million |
0.00% |
-0.33
|
- |
- |
-
|
NERV Minerva Neurosciences, Inc
|
15.8 million |
0.00% |
-1.89
|
- |
- |
-
|
NEXI NexImmune, Inc.
|
320774 |
0.00% |
-0.21
|
- |
- |
-
|
NGEN.V NERVGEN PHARMA CORP
|
131.2 million |
0.00% |
-11.42
|
- |
- |
-
|
NGM NGM Biopharmaceuticals, Inc.
|
128.5 million |
0.00% |
-0.83
|
- |
- |
-
|
NK NantKwest, Inc.
|
3.6 billion |
- |
-10.73
|
- |
- |
-
|
NKTR Nektar Therapeutics
|
242.5 million |
0.00% |
-
|
- |
- |
-
|
NKTX Nkarta, Inc.
|
186.3 million |
0.00% |
-4.16
|
- |
- |
-
|
NLTX Neoleukin Therapeutics, Inc.
|
31.5 million |
- |
-19.78
|
- |
- |
-
|
NMTR 9 Meters Biopharma, Inc.
|
11.1 million |
- |
-0.88
|
- |
- |
-
|
NNVC NanoViricides, Inc.
|
21.5 million |
0.00% |
-1.52
|
- |
- |
-
|
NOVC.DE Novo Nordisk A/S
|
370.8 billion |
1.06% |
22.93
|
1 |
22 |
12%
|
NOVN Novan, Inc.
|
33.9 million |
- |
-2.25
|
- |
- |
-
|
NOVNQ NVN Liquidation, Inc.
|
2802 |
- |
-
|
- |
- |
-
|
NRBO NeuroBo Pharmaceuticals, Inc.
|
21.6 million |
0.00% |
13.28
|
- |
- |
-
|
NRIX Nurix Therapeutics, Inc.
|
1.5 billion |
0.00% |
-
|
- |
- |
-
|
NRSN NeuroSense Therapeutics Ltd.
|
22.2 million |
0.00% |
-
|
- |
- |
-
|
NRSNW NEUROSENSE THERAPEUTICS LTD C/W
|
21.9 million |
0.00% |
-0.23
|
- |
- |
-
|
NRXP NRX Pharmaceuticals, Inc.
|
14.6 million |
0.00% |
0.36
|
- |
- |
-
|
NRXPW NRx Pharmaceuticals, Inc.
|
714.6 million |
0.00% |
-0.03
|
- |
- |
-
|
NTEC Intec Pharma Ltd
|
46.4 million |
- |
-0.47
|
- |
- |
-
|
NTII Neurobiological Technologies, Inc.
|
10862 |
1.06% |
-
|
1 |
- |
-
|
NTLA Intellia Therapeutics, Inc.
|
1.6 billion |
0.00% |
-
|
- |
- |
-
|
NTRB Nutriband Inc.
|
45.8 million |
0.00% |
-3.81
|
- |
- |
-
|
NTRBW Nutriband Inc. Warrant
|
23.3 million |
0.00% |
-0.63
|
- |
- |
-
|
NVAX Novavax, Inc.
|
1.4 billion |
0.00% |
-
|
- |
- |
-
|
NVIV InVivo Therapeutics Holdings Corp.
|
995917 |
0.00% |
-0.16
|
- |
- |
-
|
NWBO Northwest Biotherapeutics, Inc.
|
324.5 million |
0.00% |
-9.93
|
- |
- |
-
|
NXTC NextCure, Inc.
|
31.9 million |
0.00% |
-0.56
|
- |
- |
-
|
NYMX Nymox Pharmaceutical Corporation
|
43.0 million |
- |
-10.83
|
- |
- |
-
|
OBSV ObsEva SA
|
11.0 million |
- |
-1.14
|
- |
- |
-
|
OCEA Ocean Biomedical, Inc.
|
26.3 million |
0.00% |
-0.21
|
- |
- |
-
|
OCGN Ocugen, Inc.
|
253.4 million |
0.00% |
-
|
- |
- |
-
|
OCS Oculis Holding AG
|
689.2 million |
0.00% |
-
|
- |
- |
-
|
OCUL Ocular Therapeutix, Inc.
|
1.5 billion |
0.00% |
-
|
- |
- |
-
|
OCUP Ocuphire Pharma, Inc.
|
31.7 million |
0.00% |
-
|
- |
- |
-
|
ODT Odonate Therapeutics, Inc.
|
51.0 million |
- |
-3.67
|
- |
- |
-
|
OGEN Oragenics Inc.
|
3.9 million |
0.00% |
-0.80
|
- |
- |
-
|
OKYO OKYO Pharma Limited
|
34.9 million |
0.00% |
-2.68
|
- |
- |
-
|
OLMA Olema Pharmaceuticals, Inc.
|
710.1 million |
0.00% |
-6.75
|
- |
- |
-
|
OMER Omeros Corporation
|
640.9 million |
0.00% |
-1.32
|
- |
- |
-
|
OMGA Omega Therapeutics, Inc.
|
45.7 million |
0.00% |
-
|
- |
- |
-
|
ONCR Oncorus, Inc.
|
547992 |
- |
-
|
- |
- |
-
|
ONCS OncoSec Medical Incorporated
|
3.8 million |
- |
-1.88
|
- |
- |
-
|
ONCT Oncternal Therapeutics, Inc.
|
1.6 million |
0.00% |
-
|
- |
- |
-
|
ONCY Oncolytics Biotech Inc.
|
69.3 million |
0.00% |
-2.76
|
- |
- |
-
|
ONT.L OXFORD NANOPORE TECHNOLOGIES PL
|
19.1 million |
0.00% |
-10.39
|
- |
- |
-
|
ONTX Onconova Therapeutics, Inc.
|
17.6 million |
0.00% |
-0.68
|
- |
- |
-
|
ONVO Organovo Holdings, Inc.
|
6.9 million |
0.00% |
-
|
- |
- |
-
|
OPNT Opiant Pharmaceuticals, Inc.
|
108.8 million |
- |
34.80
|
- |
- |
-
|
OPORF HVIVO PLC
|
251.6 million |
0.01% |
-
|
- |
- |
-
|
OPT Opthea Limited
|
569.4 million |
0.00% |
-1.22
|
- |
- |
-
|
ORGS Orgenesis, Inc.
|
6.2 million |
0.00% |
-
|
- |
- |
-
|
ORIC Oric Pharmaceuticals, Inc.
|
709.7 million |
0.00% |
-6.39
|
- |
- |
-
|
ORMP Oramed Pharmaceuticals Inc.
|
101.2 million |
0.00% |
22.82
|
- |
- |
-
|
ORPH Orphazyme A/S
|
86.0 million |
- |
-3.59
|
- |
- |
-
|
ORTX Orchard Therapeutics plc
|
753.2 million |
- |
-4.05
|
- |
- |
-
|
OSMT Osmotica Pharmaceuticals plc
|
65.9 million |
- |
-6.37
|
- |
- |
-
|
OTIC Otonomy, Inc.
|
582482 |
- |
-3.12
|
- |
- |
-
|
OTLK Outlook Therapeutics, Inc.
|
36.0 million |
0.00% |
-1.87
|
- |
- |
-
|
OVID Ovid Therapeutics Inc.
|
73.9 million |
0.00% |
-
|
- |
- |
-
|
OYST Oyster Point Pharma, Inc.
|
298.5 million |
- |
-8.09
|
- |
- |
-
|
PALI Palisade Bio, Inc.
|
3.9 million |
0.00% |
0.02
|
- |
- |
-
|
PASG Passage Bio, Inc.
|
32.1 million |
0.00% |
-
|
- |
- |
-
|
PBLA Panbela Therapeutics, Inc.
|
1.6 million |
0.00% |
0.00
|
- |
- |
-
|
PBYI Puma Biotechnology Inc
|
145.8 million |
0.00% |
15.63
|
- |
- |
-
|
PCSA Processa Pharmaceuticals, Inc.
|
3.6 million |
0.00% |
-0.11
|
- |
- |
-
|
PCVX Vaxcyte, Inc.
|
11.6 billion |
0.00% |
-15.82
|
- |
- |
-
|
PDSB PDS Biotechnology Corporation
|
80.6 million |
0.00% |
-3.20
|
- |
- |
-
|
PGEN Precigen, Inc.
|
227.4 million |
0.00% |
-
|
- |
- |
-
|
PHAR Pharming Group N.V.
|
523.7 million |
0.00% |
-40.74
|
1 |
- |
-
|
PHARM.AS PHARMING GROUP
|
528.0 million |
0.00% |
-
|
- |
- |
-
|
PHAS PhaseBio Pharmaceuticals, Inc.
|
3.4 million |
- |
-1.33
|
- |
- |
-
|
PHAT Phathom Pharmaceuticals, Inc.
|
666.7 million |
0.00% |
-
|
- |
- |
-
|
PHGE BiomX Inc.
|
13.8 million |
0.00% |
-0.37
|
- |
- |
-
|
PHGUF Pharming Group N.V.
|
769.8 million |
- |
-38.33
|
- |
- |
-
|
PHIO Phio Pharmaceuticals Corp.
|
3.1 million |
0.00% |
0.01
|
- |
- |
-
|
PHIOW Phio Pharmaceuticals Corp.
|
421414 |
- |
-
|
- |
- |
-
|
PHM.MC PHARMA MAR, S.A.
|
1.4 billion |
0.87% |
1950
|
1 |
5 |
-
|
PHMMF PHARMA MAR SA
|
628.5 million |
0.02% |
-
|
- |
- |
-
|
PHR.WA PHARMENA
|
12.2 million |
0.00% |
1.59
|
1 |
- |
-
|
PHVS Pharvaris N.V.
|
1.0 billion |
0.00% |
-9.48
|
- |
- |
-
|
PIRS Pieris Pharmaceuticals, Inc.
|
21.9 million |
0.00% |
-
|
- |
- |
-
|
PLRX Pliant Therapeutics, Inc.
|
893.9 million |
0.00% |
-
|
- |
- |
-
|
PLX Protalix BioTherapeutics, Inc.
|
124.4 million |
0.00% |
-
|
- |
- |
-
|
PMCB PharmaCyte Biotech, Inc.
|
12.6 million |
0.00% |
2.56
|
- |
- |
-
|
PMVP PMV Pharmaceuticals, Inc.
|
82.3 million |
0.00% |
-1.14
|
- |
- |
-
|
PNT POINT Biopharma Global Inc.
|
1.5 billion |
- |
12.51
|
- |
- |
-
|
PPBT Purple Biotech Ltd.
|
4.3 million |
0.00% |
-0.78
|
- |
- |
-
|
PRAX Praxis Precision Medicines, Inc
|
1.2 billion |
0.00% |
-
|
- |
- |
-
|
PRDS Pardes Biosciences, Inc.
|
116.3 million |
- |
-
|
- |
- |
-
|
PRLD Prelude Therapeutics Incorporat
|
56.7 million |
0.00% |
-1.37
|
- |
- |
-
|
PROG Progenity, Inc.
|
340.6 million |
- |
-0.48
|
- |
- |
-
|
PRQR ProQR Therapeutics N.V.
|
365.4 million |
0.00% |
-
|
- |
- |
-
|
PRTA Prothena Corporation plc
|
756.0 million |
0.00% |
-
|
- |
- |
-
|
PRTC PureTech Health plc
|
537.0 million |
0.00% |
-14.10
|
- |
- |
-
|
PRTG Portage Biotech Inc.
|
4.5 million |
0.00% |
0.17
|
- |
- |
-
|
PRTK Paratek Pharmaceuticals, Inc.
|
106.0 million |
0.00% |
-4.84
|
- |
- |
-
|
PRVB Provention Bio, Inc.
|
2.3 billion |
- |
-9.92
|
- |
- |
-
|
PSTI Pluristem Therapeutics Inc.
|
32.1 million |
- |
-6.23
|
- |
- |
-
|
PSTV PLUS THERAPEUTICS, Inc.
|
8.2 million |
0.00% |
-
|
- |
- |
-
|
PSTX Poseida Therapeutics, Inc.
|
912.3 million |
0.00% |
-
|
- |
- |
-
|
PTCT PTC Therapeutics, Inc.
|
3.3 billion |
0.00% |
-
|
- |
- |
-
|
PTE PolarityTE, Inc.
|
3.3 million |
- |
-0.56
|
- |
- |
-
|
PTGX Protagonist Therapeutics, Inc.
|
2.5 billion |
0.00% |
15.00
|
- |
- |
-
|
PTIX Protagenic Therapeutics, Inc.
|
4.9 million |
0.00% |
-1.05
|
- |
- |
-
|
PTIXW Protagenic Therapeutics, Inc. Warrant
|
3.7 million |
0.00% |
-
|
- |
- |
-
|
PTN Palatin Technologies, Inc.
|
23.5 million |
0.00% |
-1.47
|
- |
- |
-
|
PULM Pulmatrix, Inc.
|
23.2 million |
0.00% |
-
|
- |
- |
-
|
PYPD PolyPid Ltd.
|
20.5 million |
0.00% |
-0.29
|
- |
- |
-
|
PYXS Pyxis Oncology, Inc.
|
99.9 million |
0.00% |
-
|
- |
- |
-
|
QLGN Qualigen Therapeutics, Inc.
|
3.3 million |
0.00% |
0.00
|
- |
- |
-
|
QNRX Quoin Pharmaceuticals, Ltd.
|
3.1 million |
0.00% |
2.43
|
- |
- |
-
|
QURE uniQure N.V.
|
321.2 million |
0.00% |
-
|
- |
- |
-
|
RAIN Rain Oncology Inc.
|
43.7 million |
- |
-
|
- |
- |
-
|
RAPT RAPT Therapeutics, Inc.
|
60.8 million |
0.00% |
-9.06
|
- |
- |
-
|
RARE Ultragenyx Pharmaceutical Inc.
|
4.6 billion |
0.00% |
-
|
- |
- |
-
|
RCKT Rocket Pharmaceuticals, Inc.
|
1.4 billion |
0.00% |
-
|
- |
- |
-
|
RCOR Renovacor, Inc.
|
51.2 million |
- |
-
|
- |
- |
-
|
RCUS Arcus Biosciences, Inc.
|
1.6 billion |
0.00% |
-
|
- |
- |
-
|
REGN Regeneron Pharmaceuticals, Inc.
|
85.5 billion |
0.00% |
19.26
|
- |
- |
-
|
REPL Replimune Group, Inc.
|
772.4 million |
0.00% |
-2.39
|
- |
- |
-
|
RETA Reata Pharmaceuticals, Inc.
|
3.9 billion |
- |
-13.24
|
- |
- |
-
|
REVB Revelation Biosciences, Inc.
|
1.9 million |
0.00% |
-1.19
|
- |
- |
-
|
REVBU Revelation Biosciences, Inc.
|
- |
- |
-
|
- |
- |
-
|
REVBW Revelation Biosciences, Inc.
|
1.2 million |
0.00% |
-
|
- |
- |
-
|
RGLS Regulus Therapeutics Inc.
|
104.8 million |
0.00% |
-0.89
|
- |
- |
-
|
RGNX REGENXBIO Inc.
|
513.8 million |
0.00% |
-
|
- |
- |
-
|
RIGL Rigel Pharmaceuticals, Inc.
|
466.6 million |
0.00% |
98.11
|
- |
- |
-
|
RLAY Relay Therapeutics, Inc.
|
994.3 million |
0.00% |
-
|
- |
- |
-
|
RLMD Relmada Therapeutics, Inc.
|
99.0 million |
0.00% |
-1.51
|
- |
- |
-
|
RNA Avidity Biosciences, Inc.
|
4.5 billion |
0.00% |
-
|
- |
- |
-
|
RNXT RenovoRx, Inc.
|
30.2 million |
0.00% |
-1.67
|
- |
- |
-
|
ROIV Roivant Sciences Ltd.
|
8.2 billion |
0.00% |
2.02
|
- |
- |
-
|
ROIVW Roivant Sciences Ltd. Warrant
|
- |
- |
-
|
- |
- |
-
|
ROVI.MC LABORATORIOS FARMACEUTICOS ROVI
|
3.4 billion |
0.00% |
19.47
|
1 |
17 |
30%
|
RPHM Reneo Pharmaceuticals, Inc.
|
43.8 million |
0.00% |
-0.74
|
- |
- |
-
|
RPRX Royalty Pharma plc
|
15.5 billion |
3.18% |
10.39
|
4 |
5 |
7%
|
RPTX Repare Therapeutics Inc.
|
133.9 million |
0.00% |
-
|
- |
- |
-
|
RUBY Rubius Therapeutics, Inc.
|
1.7 million |
- |
-2.31
|
- |
- |
-
|
RVMD Revolution Medicines, Inc.
|
8.9 billion |
0.00% |
-
|
- |
- |
-
|
RVNC Revance Therapeutics, Inc.
|
400.7 million |
0.00% |
-
|
- |
- |
-
|
RVPH Reviva Pharmaceuticals Holdings
|
55.2 million |
0.00% |
-2.27
|
- |
- |
-
|
RVPHW Reviva Pharmaceuticals Holdings
|
85.8 million |
0.00% |
-
|
- |
- |
-
|
RXDX Prometheus Biosciences, Inc.
|
9.3 billion |
- |
-9.98
|
- |
- |
-
|
RXRX Recursion Pharmaceuticals, Inc.
|
2.2 billion |
0.00% |
-
|
- |
- |
-
|
RYTM Rhythm Pharmaceuticals, Inc.
|
3.6 billion |
0.00% |
-
|
- |
- |
-
|
RZLT Rezolute, Inc.
|
337.2 million |
0.00% |
-0.96
|
- |
- |
-
|
SABS SAB Biotherapeutics, Inc.
|
28.3 million |
0.00% |
-
|
- |
- |
-
|
SABSW SAB Biotherapeutics, Inc.
|
54.9 million |
0.00% |
0.26
|
- |
- |
-
|
SAGE Sage Therapeutics, Inc.
|
342.8 million |
0.00% |
-
|
- |
- |
-
|
SANA Sana Biotechnology, Inc.
|
640.8 million |
0.00% |
-4.37
|
- |
- |
-
|
SAVA Cassava Sciences, Inc.
|
146.0 million |
0.00% |
-10.39
|
- |
- |
-
|
SBBP Strongbridge Biopharma plc
|
135.5 million |
- |
-3.29
|
- |
- |
-
|
SBPH Spring Bank Pharmaceuticals, In
|
5.2 million |
- |
-0.81
|
- |
- |
-
|
SBTX Silverback Therapeutics, Inc.
|
206.2 million |
- |
-
|
- |
- |
-
|
SCPH scPharmaceuticals Inc.
|
172.6 million |
0.00% |
-
|
- |
- |
-
|
SCPS Scopus BioPharma Inc.
|
294590 |
- |
-0.02
|
- |
- |
-
|
SEEL Seelos Therapeutics, Inc.
|
429940 |
0.00% |
0.00
|
- |
- |
-
|
SEER Seer, Inc.
|
146.2 million |
0.00% |
-
|
- |
- |
-
|
SELB Selecta Biosciences, Inc.
|
153.4 million |
- |
10.41
|
- |
- |
-
|
SEPN Septerna, Inc. Common Stock
|
1.1 billion |
0.00% |
-52.68
|
- |
- |
-
|
SESN Sesen Bio, Inc.
|
119.3 million |
- |
1.91
|
1 |
1 |
-
|
SGEN Seagen Inc.
|
41.2 billion |
6.15% |
-54.52
|
- |
- |
-
|
SGMO Sangamo Therapeutics, Inc.
|
563.2 million |
0.00% |
-
|
- |
- |
-
|
SGTX Sigilon Therapeutics, Inc.
|
18.2 million |
- |
-
|
- |
- |
-
|
SIOX Sio Gene Therapies Inc.
|
28.8 million |
- |
-1
|
- |
1 |
-
|
SLDB Solid Biosciences Inc.
|
193.8 million |
0.00% |
-
|
- |
- |
-
|
SLGL Sol-Gel Technologies Ltd.
|
14.9 million |
0.00% |
-
|
- |
- |
-
|
SLN Silence Therapeutics Plc - Amer
|
402.3 million |
0.00% |
-14.03
|
- |
- |
-
|
SLNO Soleno Therapeutics, Inc.
|
2.1 billion |
0.00% |
-15.10
|
- |
- |
-
|
SLRN ACELYRIN, INC.
|
563.9 million |
0.00% |
-1.60
|
- |
- |
-
|
SLRX Salarius Pharmaceuticals, Inc.
|
2.2 million |
0.00% |
-0.09
|
- |
- |
-
|
SLS SELLAS Life Sciences Group, Inc
|
80.2 million |
0.00% |
-0.50
|
- |
- |
-
|
SMMT Summit Therapeutics Inc.
|
14.4 billion |
0.00% |
19.05
|
- |
- |
-
|
SMSLIFE.BO SMS Lifesciences India Ltd
|
41.9 million |
0.00% |
16.23
|
- |
4 |
-
|
SMSLIFE.NS SMS LIFESCIENCES (I) LTD
|
41.7 million |
0.00% |
16.16
|
- |
4 |
-
|
SNDX Syndax Pharmaceuticals, Inc.
|
1.4 billion |
0.00% |
-
|
- |
- |
-
|
SNGX Soligenix, Inc.
|
8.1 million |
0.00% |
-
|
- |
- |
-
|
SNPX Synaptogenix, Inc.
|
4.3 million |
0.00% |
0.31
|
- |
- |
-
|
SNSE Sensei Biotherapeutics, Inc.
|
14.1 million |
0.00% |
-0.61
|
- |
- |
-
|
SONN Sonnet BioTherapeutics Holdings
|
1.8 million |
0.00% |
-
|
- |
- |
-
|
SPHS Sophiris Bio, Inc.
|
34 |
- |
0.00
|
- |
- |
-
|
SPPI Spectrum Pharmaceuticals, Inc.
|
266.9 million |
0.00% |
-2.93
|
- |
- |
-
|
SPRB Spruce Biosciences, Inc.
|
20.6 million |
0.00% |
-
|
- |
- |
-
|
SPRC SciSparc Ltd.
|
2.4 million |
0.00% |
0.01
|
- |
- |
-
|
SPRO Spero Therapeutics, Inc.
|
63.2 million |
0.00% |
14.50
|
4 |
- |
-
|
SQZ SQZ Biotechnologies Company
|
19.0 million |
- |
-
|
- |
- |
-
|
SRNE Sorrento Therapeutics, Inc.
|
168.4 million |
- |
-4.43
|
- |
- |
-
|
SRPT Sarepta Therapeutics, Inc.
|
12.4 billion |
0.00% |
84.20
|
- |
- |
-
|
SRRA Sierra Oncology, Inc.
|
827.9 million |
- |
-1.06
|
- |
- |
-
|
SRRK Scholar Rock Holding Corporatio
|
2.6 billion |
0.00% |
-7.72
|
- |
- |
-
|
SRZN Surrozen, Inc.
|
32.2 million |
0.00% |
-0.51
|
- |
- |
-
|
SRZNW Surrozen, Inc.
|
331.7 million |
- |
-
|
- |
- |
-
|
STAB Statera Biopharma, Inc.
|
42850 |
0.00% |
-
|
- |
- |
-
|
STOK Stoke Therapeutics, Inc.
|
737.3 million |
0.00% |
-
|
- |
- |
-
|
STRO Sutro Biopharma, Inc.
|
229.2 million |
0.00% |
-
|
- |
- |
-
|
STSA Satsuma Pharmaceuticals, Inc.
|
34.8 million |
0.72% |
-1.58
|
3 |
- |
-
|
STTK Shattuck Labs, Inc.
|
59.7 million |
0.00% |
-
|
- |
- |
-
|
SUPRIYA.BO Supriya Lifescience Limited
|
756.3 million |
0.00% |
40.66
|
- |
3 |
-
|
SUPRIYA.NS SUPRIYA LIFESCIENCE LTD
|
756.8 million |
0.00% |
40.73
|
- |
3 |
-
|
SURF Surface Oncology, Inc.
|
37.6 million |
- |
0.98
|
- |
- |
-
|
SVA Sinovac Biotech Ltd.
|
642.4 million |
2.82% |
6.66
|
- |
- |
-
|
SVRA Savara, Inc.
|
627.1 million |
0.00% |
-15.65
|
- |
- |
-
|
SWTX SpringWorks Therapeutics, Inc.
|
3.1 billion |
0.00% |
-
|
- |
- |
-
|
SYBX Synlogic, Inc.
|
17.1 million |
0.00% |
-
|
- |
- |
-
|
SYN Synthetic Biologics, Inc.
|
134.7 million |
- |
-0.48
|
- |
- |
-
|
SYNGENE.BO Syngene International Limited
|
4.4 billion |
0.15% |
77.57
|
- |
3 |
-
|
SYNGENE.NS SYNGENE INTERNATIO
|
4.4 billion |
0.14% |
77.95
|
- |
3 |
-
|
SYRS Syros Pharmaceuticals, Inc.
|
7.4 million |
0.00% |
-
|
- |
- |
-
|
TALS Talaris Therapeutics, Inc.
|
125.7 million |
- |
-
|
- |
- |
-
|
TARA Protara Therapeutics, Inc.
|
51.0 million |
0.00% |
-0.45
|
- |
- |
-
|
TARS Tarsus Pharmaceuticals, Inc.
|
1.7 billion |
0.00% |
-
|
- |
- |
-
|
TBPH Theravance Biopharma, Inc.
|
483.4 million |
0.00% |
-
|
- |
- |
-
|
TCDA Tricida, Inc.
|
2.4 million |
- |
-1.20
|
- |
- |
-
|
TCON TRACON Pharmaceuticals, Inc.
|
109725 |
0.00% |
0.01
|
- |
- |
-
|
TCRR TCR2 Therapeutics Inc.
|
77.7 million |
- |
-11.16
|
- |
- |
-
|
TCRT Alaunos Therapeutics, Inc.
|
3.2 million |
0.00% |
-1.04
|
- |
- |
-
|
TCRX TScan Therapeutics, Inc.
|
258.8 million |
0.00% |
-
|
4 |
- |
-
|
TECH Bio-Techne Corp
|
11.9 billion |
0.43% |
78.96
|
4 |
17 |
13%
|
TENX Tenax Therapeutics, Inc.
|
20.1 million |
0.00% |
-0.10
|
- |
- |
-
|
TERN Terns Pharmaceuticals, Inc.
|
524.1 million |
0.00% |
-6.83
|
- |
- |
-
|
TFFP TFF Pharmaceuticals, Inc.
|
1.1 million |
0.00% |
-
|
- |
- |
-
|
TGTX TG Therapeutics, Inc.
|
4.6 billion |
0.00% |
-
|
- |
- |
-
|
THRD Third Harmonic Bio, Inc.
|
527.2 million |
0.00% |
12.71
|
- |
- |
-
|
THRX Theseus Pharmaceuticals, Inc.
|
181.3 million |
0.00% |
-3.03
|
3 |
- |
-
|
THTX Theratechnologies Inc.
|
67.2 million |
0.00% |
-
|
- |
- |
-
|
TIL Instil Bio, Inc.
|
172.9 million |
0.00% |
-
|
- |
- |
-
|
TITANBIO.BO TITAN BIOTECH LTD.
|
77.1 million |
0.00% |
27.64
|
1 |
5 |
10%
|
TLC Taiwan Liposome Company, Ltd.
|
294.5 million |
- |
-5.13
|
- |
- |
-
|
TLOG TetraLogic Pharmaceuticals Corporation
|
458720 |
4.85% |
-0.02
|
- |
- |
-
|
TLSA Tiziana Life Sciences Ltd
|
105.9 million |
0.00% |
-3.58
|
- |
- |
-
|
TMBR Timber Pharmaceuticals, Inc.
|
1.3 million |
- |
-0.05
|
- |
- |
-
|
TNGX Tango Therapeutics, Inc.
|
359.9 million |
0.00% |
-
|
- |
- |
-
|
TNXP Tonix Pharmaceuticals Holding C
|
30.4 million |
0.00% |
-
|
- |
- |
-
|
TPST Tempest Therapeutics, Inc.
|
38.3 million |
0.00% |
-1.90
|
- |
- |
-
|
TPTX Turning Point Therapeutics, Inc.
|
3.8 billion |
- |
-31.45
|
- |
- |
-
|
TRDA Entrada Therapeutics, Inc.
|
744.0 million |
0.00% |
13.81
|
- |
- |
-
|
TRIL Trillium Therapeutics Inc.
|
1.9 billion |
5.56% |
-10.91
|
- |
- |
-
|
TRML Tourmaline Bio, Inc.
|
616.3 million |
- |
-9.65
|
- |
1 |
-
|
TRVI Trevi Therapeutics, Inc.
|
199.9 million |
0.00% |
-7.45
|
- |
- |
-
|
TRVN Trevena, Inc.
|
1.6 million |
0.00% |
-0.10
|
- |
- |
-
|
TSHA Taysha Gene Therapies, Inc.
|
487.8 million |
0.00% |
3.78
|
- |
- |
-
|
TSVT 2seventy bio, Inc.
|
181.6 million |
0.00% |
-
|
- |
- |
-
|
TTNP Titan Pharmaceuticals, Inc.
|
3.8 million |
0.00% |
-0.88
|
- |
- |
-
|
TUB.BR TUBIZE-FIN
|
6.5 billion |
0.72% |
67.49
|
1 |
25 |
30%
|
TVTX Travere Therapeutics, Inc.
|
1.5 billion |
0.00% |
-
|
- |
- |
-
|
TYME Tyme Technologies, Inc.
|
53.5 million |
- |
-4.02
|
- |
- |
-
|
TYRA Tyra Biosciences, Inc.
|
767.6 million |
0.00% |
-13.16
|
- |
- |
-
|
UBX Unity Biotechnology, Inc.
|
22.1 million |
0.00% |
-0.53
|
- |
- |
-
|
UCB.BR UCB
|
36.7 billion |
0.75% |
149.18
|
1 |
25 |
-15%
|
UCBJF UCB S.A.
|
23.2 billion |
0.01% |
64.21
|
- |
- |
-
|
UCBJY UCB S.A. UNSP ADR EACH REPR 0.5
|
37.0 billion |
0.02% |
150.03
|
1 |
15 |
-
|
UNCY Unicycive Therapeutics, Inc.
|
45.1 million |
0.00% |
-0.76
|
- |
- |
-
|
UPB Upstream Bio, Inc.
|
1.2 billion |
0.00% |
-15.90
|
- |
- |
-
|
URGN UroGen Pharma Ltd.
|
518.6 million |
0.00% |
-
|
- |
- |
-
|
UTHR United Therapeutics Corporation
|
17.2 billion |
0.00% |
17.61
|
- |
- |
-
|
VACC Barinthus Biotherapeutics plc
|
192.7 million |
- |
15.64
|
- |
- |
-
|
VALN Valneva SE
|
418.2 million |
0.00% |
-
|
- |
- |
-
|
VAXX Vaxxinity, Inc.
|
1.3 million |
0.00% |
-1.34
|
- |
- |
-
|
VBIV VBI Vaccines, Inc.
|
1.9 million |
0.00% |
-
|
1 |
- |
-
|
VBLT Vascular Biogenics Ltd.
|
15.0 million |
8.81% |
-2.03
|
- |
- |
-
|
VCEL Vericel Corporation
|
2.9 billion |
0.00% |
725
|
- |
- |
-
|
VCNX Vaccinex, Inc.
|
9.0 million |
0.00% |
-0.10
|
- |
- |
-
|
VECT VectivBio Holding AG
|
799.9 million |
- |
-
|
- |
- |
-
|
VERA Vera Therapeutics, Inc.
|
3.0 billion |
0.00% |
-15.11
|
- |
- |
-
|
VERU Veru Inc.
|
104.5 million |
0.00% |
-
|
4 |
- |
-
|
VERV Verve Therapeutics, Inc.
|
490.2 million |
0.00% |
-
|
- |
- |
-
|
VIGL Vigil Neuroscience, Inc.
|
96.1 million |
0.00% |
-1.45
|
- |
- |
-
|
VINC Vincerx Pharma, Inc.
|
11.2 million |
0.00% |
-0.68
|
- |
- |
-
|
VIR Vir Biotechnology, Inc.
|
1.2 billion |
0.00% |
-
|
- |
- |
-
|
VIRI Virios Therapeutics, Inc.
|
4.7 million |
0.00% |
-2.54
|
- |
- |
-
|
VIRX Viracta Therapeutics, Inc.
|
6.2 million |
0.00% |
-0.51
|
- |
- |
-
|
VKTX Viking Therapeutics, Inc.
|
7.0 billion |
0.00% |
-30.41
|
- |
- |
-
|
VLA.PA VALNEVA SE
|
441.8 million |
0.00% |
-
|
- |
- |
-
|
VNDA Vanda Pharmaceuticals Inc.
|
281.0 million |
0.00% |
-
|
- |
- |
-
|
VOR Vor Biopharma Inc.
|
61.3 million |
0.00% |
-1.17
|
- |
- |
-
|
VRCA Verrica Pharmaceuticals Inc.
|
42.3 million |
0.00% |
-
|
- |
- |
-
|
VRNA Verona Pharma plc
|
3.3 billion |
0.00% |
-
|
- |
- |
-
|
VRPX Virpax Pharmaceuticals, Inc.
|
3.0 million |
0.00% |
-0.32
|
- |
- |
-
|
VRTX Vertex Pharmaceuticals Incorpor
|
122.1 billion |
0.00% |
-
|
- |
- |
-
|
VSTM Verastem, Inc.
|
195.8 million |
0.00% |
-
|
- |
- |
-
|
VTGN VistaGen Therapeutics, Inc.
|
72.3 million |
0.00% |
-
|
- |
- |
-
|
VTVT vTv Therapeutics Inc.
|
45.9 million |
0.00% |
-0.96
|
- |
- |
-
|
VTYX Ventyx Biosciences, Inc.
|
220.6 million |
0.00% |
-0.70
|
- |
- |
-
|
VXRT Vaxart, Inc. - Common Stock
|
142.9 million |
0.00% |
-
|
- |
- |
-
|
VYGR Voyager Therapeutics, Inc.
|
308.1 million |
0.00% |
20.89
|
- |
- |
-
|
VYNE VYNE Therapeutics Inc.
|
39.5 million |
0.00% |
0.81
|
- |
- |
-
|
VYNT Vyant Bio, Inc.
|
1.2 million |
- |
0.65
|
- |
- |
-
|
WINT Windtree Therapeutics, Inc.
|
5.2 million |
0.00% |
0.88
|
- |
- |
-
|
WVE Wave Life Sciences Ltd.
|
2.3 billion |
0.00% |
-
|
- |
- |
-
|
WXIBF WuXi Biologics (Cayman) Inc.
|
25.6 billion |
- |
46.31
|
- |
- |
-
|
WXXWY Wuxi Biologics (Cayman) Inc
|
9.1 billion |
0.00% |
25.12
|
- |
- |
-
|
XBIO Xenetic Biosciences, Inc.
|
7.0 million |
0.00% |
-
|
- |
- |
-
|
XBIT XBiotech Inc.
|
218.0 million |
0.00% |
-
|
- |
- |
-
|
XCUR Exicure, Inc.
|
6.3 million |
0.00% |
-
|
- |
- |
-
|
XENE Xenon Pharmaceuticals Inc.
|
3.3 billion |
0.00% |
-18.81
|
- |
- |
-
|
XERS Xeris Biopharma Holdings, Inc.
|
454.7 million |
0.00% |
-
|
- |
- |
-
|
XFOR X4 Pharmaceuticals, Inc.
|
62.8 million |
0.00% |
-
|
- |
- |
-
|
XLO Xilio Therapeutics, Inc.
|
45.7 million |
0.00% |
-
|
- |
- |
-
|
XLRN Acceleron Pharma Inc.
|
10.9 billion |
- |
-41.22
|
- |
- |
-
|
XNCR Xencor, Inc.
|
1.7 billion |
0.00% |
-
|
- |
- |
-
|
XOMA XOMA Royalty Corporation
|
362.1 million |
0.00% |
-
|
- |
- |
-
|
XOMAO XOMA Royalty Corporation - Depo
|
228.4 million |
0.00% |
25.30
|
4 |
4 |
30%
|
XOMAP XOMA Royalty Corporation - 8.62
|
234.3 million |
0.00% |
25.83
|
4 |
4 |
7%
|
XRTX XORTX Therapeutics Inc.
|
3.9 million |
0.00% |
10
|
- |
- |
-
|
XTLB XTL Biopharmaceuticals Ltd.
|
10.6 million |
0.00% |
-2.29
|
- |
- |
-
|
YECO EV Biologics, Inc.
|
6.1 million |
- |
-0.49
|
- |
- |
-
|
YMAB Y-mAbs Therapeutics, Inc.
|
476.6 million |
0.00% |
-
|
- |
- |
-
|
YMTX Yumanity Therapeutics, Inc.
|
22.0 million |
- |
-
|
1 |
1 |
-
|
ZEAL Zealand Pharma A/S
|
814.1 million |
- |
-13.97
|
- |
- |
-
|
ZGNX Zogenix, Inc.
|
892.0 million |
- |
-3.56
|
- |
- |
-
|
ZIOP ZIOPHARM Oncology, Inc.
|
220.5 million |
- |
-7.57
|
- |
- |
-
|
ZIVO Zivo Bioscience, Inc.
|
72.7 million |
0.00% |
-1.36
|
- |
- |
-
|
ZIVOW Zivo Bioscience, Inc.
|
35.3 million |
0.00% |
-
|
- |
- |
-
|
ZLAB Zai Lab Limited
|
3.0 billion |
0.00% |
-
|
- |
- |
-
|
ZNTL Zentalis Pharmaceuticals, Inc.
|
243.4 million |
0.00% |
-
|
- |
- |
-
|
ZOTA.NS ZOTA HEALTH CARE LIMITED
|
201.7 million |
0.00% |
-67.37
|
- |
8 |
4%
|
ZSAN Zosano Pharma Corporation
|
66.0 million |
- |
-0.33
|
- |
- |
-
|
ZYME Zymeworks Inc.
|
984.3 million |
0.00% |
-
|
- |
- |
-
|